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ABSTRACT 
 
Haliotis Rubra hemocyanin is a promising antiviral candidate for treating Herpes Simples Viruses, 
however this protein is not stable and forms irreversible aggregates, destroying any therapeutic 
activity. In this study we have analysed the stability of this protein, developing diagnostic techniques 
for measuring its stability, and have created a stable formulation which maintains its native structure 
even after long term storage. This work will allow us to properly test the antiviral activity of the protein 
by ensuring it reaches drug trials in a stable reactive form. 
The extreme size of hemocyanins requires specialist techniques to study as they do not readily diffuse 
into electrophoresis gels and tend to aggregate easily. As the genome for Haliotis Rubra has not been 
investigated we have instead compared the primary structure of the hemocyanin to those for 
hemocyanin from other species using Mass Spectrometry, identifying that the Haliotis Rubra has high 
homology to Haliotis Tuberculata. Photon Correlation spectroscopy was then applied to identify a 
solubilised structure with a diameter of 44nm, indicating that the hemocyanin has a similar size shape 
and structure to the Haliotis Tuberculata didecamer with a molecular weight of 7.39MDa. This makes 
our hemocyanin one of the largest proteins to be studied. 
Differential scanning calorimetry was then applied to the study of hemocyanin denaturation. The high 
resolution TA nanoDSC allowed calorimetric data to be obtained without the onset of aggregation 
during the denaturation transition. For the first time with Haliotis Rubra calorimetric traces have been 
obtained, with a denaturation temperature of 76.3oC showing that the stability of the pure protein 
was comparable to that from other species. Similarly to other hemocyanins which have been studied, 
the denaturation reaction was found to be entirely irreversible, necessitating the use of irreversible 
denaturation models for its study. The method of Sanchez-Ruiz was therefore applied, identifying an 
activation energy for the denaturation reaction of 528 ± 63 kJ mol-1.  
It was determined that whilst the hemocyanin has a complex quaternary structure, this oligomeric 
form does not change during the denaturation. Aggregation, however, did occur alongside 
denaturation, with all samples showing visible aggregates upon removal from the calorimeter. Photon 
correlation spectroscopy was therefore applied, observing the onset of hemocyanin aggregation for 
the protein at 76oC, simultaneously to the denaturation. This method is novel to the study of proteins 
as extremely large molecular weights are required for testing, however this proved to be a simple and 
effective method for measuring the aggregation state of hemocyanin and may be widely applicable to 
the study of other large aggregating proteins. 
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The stability of this hemocyanin was then improved through formulation, with the effect of buffers, 
salts and sugars investigated as candidate stabilising adjuvants. All sugars promoted stable 
formulations, likely due to the excluded volume effect, with a maximum suitable concentration only 
limited by the solubility of the sugar. Buffers were found to have specific interactions with the protein, 
resulting in either a strongly destabilising effect or a promotion of stability and increase of 
denaturation temperature. Both TRIS and HEPES were strongly stabilising. Salts were found to stabilise 
the protein at certain concentrations, as long as divalent cations were not included, with an optimum 
concentration of 100mM observed.  
In order to combine the stabilising adjuvants into a single formulation we identified the optimum 
mixture to be a 50mM HEPES at pH 7.4 with 100 mM NaCl and 100 mM sucrose solution which was 
formulated with 1 mg mL-1 Haliotis Rubra hemocyanin. This resulted in a stabilised formulation with a 
denaturation temperature of 78.9oC and a denaturation activation energy of 726 kJ mol-1, a 
stabilisation improvement by 38%.  
This sample was then stored for nine months, with the sample retaining its thermal stability and 
oligomeric state. As we have formulated the protein into a solvent with FDA approved adjuvants and 
proven long term stability, the hemocyanin sample is now suitable for therapeutic testing. Creating a 
stable hemocyanin formulation will allow for viable drug testing and will show the true efficacy of 
native Haliotis Rubra hemocyanin. 
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Aciclovir A family of drugs used to treat viral infections, most commonly HSV 
infections. 
Adjuvant An added ingredient used in a formulation 
AH Abalone Hemocyanin 
Alpha Helix  
(α-helix) 
A common shape in protein secondary structures 
apo form Form of a protein with no bound oxygen 
Beta Sheet  
(β-sheet) 
A common shape in protein secondary structures 
Bis-Tris A buffer of Bis and TRIS 
BLAST A database of genomes used to match possible species for the source of a 
protein 
CD Circular Dichroism 
chaotrope An agent which disrupts the hydrogen bonding of water 
Cp Heat Capacity 
Decamer A quaternary structure composed of 10 subunits 
Deconvolute To separate multiple signals from a single curve. 
Denaturation 
Temperature (Td) 
The temperature at which the protein structure is disrupted 
Didecamer A quaternary Structure composed of 20 subunits 
divalent an ion with a charge of 2 
DSC  Differential Scanning Calorimetry 
DSC trace The curve obtained from a DSC scan showing change in heat capacity as 
temperature is varied 
Ea Activation Energy 
excipient A non-active component in the drug formulation 
FDA The Food and Drug Administration of the USA 
FS  Flourescence Spectroscopy 
FTIR Fourier Transform Ifrared Spectroscopy 
Gibbs free energy 
(G) 
A measure of total energy combining enthalpic and entropic contributions. 
Systems with lower total Gibbs free energy will be more stable than those 
with high Gibbs free energy. 
Glycosylation The binding of glycans (sugars) to a protein 
Hastelloy A Low corrosion Metal 
Heat Capacity 
(Cp) 
The amount of heat required to increase the temperature of a sample. 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid - A buffer 
HSV Herpes Simplex Virus 
IEF Isoelectric Focussing Gel Electrophoresis 
kD reaction rate constant 
KLH Key Hole Limpet Hemocyanin 
LCMS Liquid Chromatography Mass Spectrometry 
lyophilisation  Freeze drying 
MASCOT A protein sequence database used for identifying the source of protein 
fragments 
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MDa Megadalton, a unit of mass 
mM milliMolar - a measure of molar concentration 
Monomer A unit which can be bonded to other like units in a polymeric structure 
MS  Mass Spectrometry 
Oligomer A complex which contains a few monomeric units 
osmolyte Dissolved species which contribute to the ionic concentration of the sample. 
oxy form Oxygenated form of a protein 
PAGE Polyacrylamide Gel Electrophoresis 
PBS Phosphine buffered saline - A buffer 
PCS Photon Correlation Spectroscopy 
pH  Potential of Hydrogen - A measure of relative acidity 
phylum A taxonomic category, ranking below kingdom 
pI Isoelectric Point 
pOH Potential of Hydroxide - A measure of relative basisity 
Primary Structure The amino acid sequence of a protein 
Q Measured heat output  at a point 
Qt Total heat evolved in a transition 
Quaternary 
structure 
The total structure formed when multiple polypeptide chains are included 
together in a protein 
R  Universal Gas Constant 
Recombinant A technique for producing proteins artificially 
Secondary 
Structure 
The folding configuration of part of a protein sequence 
T Temperature 
Tertiary Structure The complete folded structure of a single protein polypeptide chain 
Tm Melt temperature, the temperature of unfolding for a polymer (or protein) 
TOF Time of Flight 
TRIS trisaminomethane - A common buffer used in protein formulations 
Tris-Acetate A buffer of Tris and Acetate 
Z-average The Z average is the intensity weighted mean hydrodynamic size of the 
ensemble collection of particles measured by dynamic light scattering (DLS). 
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CHAPTER 1. Introduction 
Protein and peptide therapeutics are an increasingly important part of our pharmaceutical arsenal, 
with treatments from insulin replacement to novel antivirals becoming widespread[3]. Therapeutic 
proteins are not without their challenges, however, with initial candidates having low stability [4, 5] 
and therapeutic windows. 
The efficacy of any protein pharmaceutical is limited by our ability to maintain the stability of the 
active protein. A protein which may have extremely strong drug action will not, if allowed to denature, 
aggregate or be removed from solution, show that activity in drug trials[6]. Before attempting such 
drug trials, therefore, it is crucial to create a stable protein formulation and to know under what 
conditions this stability will be maintained.  
In order to create such a protein formulation we will need to understand the core properties of the 
protein, including what conditions will maintain or reduce this stability. Tools which can reliably 
measure if the formulation is stable must be validated, and such tools must be available to test the [7] 
formulation as it is used in drug trials. 
Hemocyanins are a class of proteins which have been widely considered for their potential therapeutic 
responses to a wide range of conditions, from cancer [8] to viruses [9] with the effects varying 
dramatically based on the species of origin for the protein. Our lab has been studying the hemocyanin 
from Haliotis Rubra, specifically looking at its effect on the Herpes Simplex Virus family. 
Herpes simplex viruses (HSV) affect nearly 75% of the Australian population (worldwide 55-90% with 
HSV-1) from which 20-25% develop painful, chronic and recurrent infections[10-12]. However to date 
no cure has been suggested for HSVs and current treatments only temporarily treat the symptoms of 
HSV infection. For this purpose the Aciclovir family of drugs being the only effective treatments 
currently available. These drugs treat the symptoms of herpes infections by inhibiting the viral DNA 
polymerase[13]. These treatments are therefore susceptible to drug resistance [10]and should be 
complemented with antiviral drugs which work via a different mechanism.  
Whist hemocyanins have exciting therapeutic possibilities, their use is challenging due to the size and 
complexity of the protein [14], including a didecameric quaternary structure of up to 8 MDa[15], 
making them one of the largest protein families in existence. This means that normal formulation 
methods may not be suitable and as the solvation characteristics of the protein are vastly different 
from small peptides [16]. Further, whist most therapeutic proteins are now expressed recombinantly, 
hemocyanins are a poor candidate for this due to their size, complexity and glycosylation [17]. As it 
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may be possible that these factors are crucial to the drug action of the protein, we must investigate 
the protein by purifying it directly from the animal itself. 
The aim of this study was, therefore, to create a verifiably stable formulation of Haliotis Rubra 
hemocyanin and a set of tools to verify its stability. In order to do this it is crucial to define the core 
properties of the protein, its stability, and to investigate all possible stabilising agents at our disposal. 
In order to arrive at a complete stable formulation, we have structured this research in a linear 
sequence first investigating tools to validate stability, then using those tools to define the stability of 
the unformulated protein. A list of possible stabilising adjuvants may then be compiled and 
investigated before creating a formulation which combined the most favourable conditions identified. 
It is hoped that a combination of these factors may allow for a formulation which would be suitable 
for drug testing.   
Hemocyanins were first identified in 1900 and much research has been undertaken on their 
properties. Whilst this research has clearly shown that the properties of a hemocyanin are a factor of 
the species from which it is drawn, many possible avenues for investigating the stability of this protein 
exist in the literature. A review of this data, as well as the available methods for measuring and 
improving protein stability will be conducted in Chapter Two. 
The physical properties of Haliotis Rubra hemocyanin will then be investigated in Chapter Three. As 
the genome for Haliotis Rubra has not been sequenced, and therefore the primary structure of its 
hemocyanin unknown, we will derive core information about the size, primary structure, aggregation 
and diffusion properties of the protein indirectly. These properties are key to establishing baseline 
properties of the protein so that we may have the core data required for models of the hemocyanin 
thermal stability, the properties of any aggregates formed and the possible quaternary arrangements 
of the protein. 
Chapter Four will then investigate the thermal stability of Haliotis Rubra hemocyanin, investigating 
whether the protein may denature reversibly and what methods may be used to quantify the stability 
of the protein by analysing its denaturation behaviour. The previously derived information of the size 
and structure may allow us to calculate the activation energy of the hemocyanins denaturation 
reactions and to create baseline comparisons for data on the aggregation state of the hemocyanin 
before, during and after denaturation. 
Further, in Chapter Five, we will formulate the hemocyanin into a variety of buffer and adjuvant 
solutions, comparing the stability of these formulations to that of the pure hemocyanin. Previous 
studies into the stabilising and destabilising effects of various adjuvants allow us to make predictions 
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on what the effect of each of these additives may have on hemocyanin stability, however, due to the 
extreme size of the protein, as well as its unique properties, such as its high copper content, we 
anticipate that hemocyanin may not respond in the same manner as most small proteins would to this 
formulation. Indeed the extreme differences in stability properties measured for hemocyanins from 
other species suggests that a formulation tailored specifically to this hemocyanin may be needed in 
order to ensure its stability. 
Finally we will combine and summarise the findings of this research in Chapter Six. Further lines of 
inquiry into the stability of other large proteins, and other experimental techniques which could be 
relevant to studying the stability of hemocyanins and indeed all large proteins will be investigated. As 
there are so many unusual variables involved in measuring the properties of such a large protein, we 
anticipate that many avenues for investigation will exist which may provide further insights. Study of 
the specific therapeutic effects of hemocyanin into herpes simplex viruses as well as other ailments 
will be considered,  
It is hoped that by investigating the core stability issues of Haliotis Rubra hemocyanin we may facilitate 
the creation of viable and effective therapeutic Haliotis Rubra hemocyanin formulations and 
potentially give some frameworks into creating therapeutics from hemocyanins and other large 
proteins which may applied as broadly as possible. 
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CHAPTER 2. Literature Review 
In the following section we shall investigate the current literature covering protein structure, stability, 
the formulation of protein pharmaceuticals. This will include an evaluation of the relevant structural 
elements of hemocyanins, and proteins more generally.  
2.1. Protein Stability 
2.1.1. Structure of proteins 
Proteins make up a large portion of the biomass within all living organisms, constituting the structure 
of cells, accounting for most of the cells mass and performing the bodily functions of the organism[18, 
19] such as respiration, for which hemocyanins are responsible[20]. Information about both the 
covalent and folded structures of the protein are relevant to the relative stability of the various protein 
molecules, and hence shall be described here.   
The primary structure of the protein is defined by the polypeptide sequence of bound amino acid 
residues which are synthesised within cells by the condensation reaction between amino acids to form 
peptide bonds between the carboxyl group and the amino group of two amino acids. Twenty different 
amino acids, defined by the structure of their side chain, are utilised to create polypeptides with a 
variety of different properties. As some amino acid residues are polar and others are non-polar, the 
protein will fold into a structure where the non-polar residues are shielded from the surrounding 
water molecules, whist the polar residues are free to interact with water and other polar residues 
through a number of intermolecular forces[21]. This creates a situation where the folded structure is 
thermodynamically favourable to the unfolded structure, as the free energy of the system with a 
folded protein in water is lower than that of an unfolded protein[22]. The total molecular weight, 
solubility and ionic charge will be determined by the proteins primary structure. 
The secondary structure of the protein consists of the folded shapes which are formed in the hiding 
of non-polar residues, within segments of a protein chains primary structure. The two most common 
folding patterns are the α-helix and the β-sheet. They are predominantly stabilised by the hydrogen 
bonding between amide and carboxylic acid groups on the protein side chains. An α-helix is formed 
when the polypeptide chain coils around itself, hydrogen bonding between every four amino acid 
residues. A β-sheet, however, forms when hydrogen bonding occurs between segments of the 
polypeptide chain which lie parallel to each other[18]. Most proteins form some combination of α-
helices and β-sheets, connected by unstructured linking sections. The final shape, function and 
stability will be determined by the relative prevalence of secondary structure elements in the final 
structure[23].  
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The tertiary structure of the protein is comprised of the complete folded structure of an entire 
polypeptide chain. It is determined by the arrangement of all the secondary structure elements 
present in the polypeptide and is stabilised by a range of intermolecular forces, including hydrogen 
bonding, hydrophilic and hydrophobic interactions and Van der Waals forces[24]. These interactions 
exist particularly between the various side chains of the amino acid residues and between the side 
chains and the solvent in the system[25].  
For complex proteins, in which multiple polypeptide chains assemble to form the complete protein, a 
further level of organisation, called the quaternary structure, exists. In this structure each individual 
polypeptide is referred to as subunit. The structure may consist of repeating identical subunits, such 
as in keratin [26], or contain different subunits, such as haemoglobins [27]. Hemocyanins have been 
shown to form a series of different complex quaternary structures, depending on the phylum from 
which they are extracted [20, 28, 29].  
Upon denaturation, proteins unfold and refold into many different conformations. This changes are 
most pronounced in the secondary and tertiary structures, however separation of the quaternary 
structure prior to denaturation is often observed. The primary structure of the protein, however, is 
not disturbed during denaturation. It has been suggested that during reversible denaturations the 
structure of the protein does not change dramatically and there is more likely an expansion of the 
original shape and a loss of intramolecular bonding [30]. Separation of secondary structures from α-
helicies into β-sheets or random coils, is also observed[31, 32]. This leads to a final denatured structure 
most often referred to as a molten globule[33]. 
 
2.1.2. How to define stability of ideal protein systems 
A stable protein may be defined as one which is in its natural functional state. This requires that the 
protein has preserved its primary structure and is correctly folded state[32]. Naturally, this is the state 
which a protein will be found when functioning within an organism. This correctly folded state is one 
maintained as a thermodynamic local energy minimum of the entire protein and solvent system, 
which we describe with the Gibbs free energy function. The stable state will therefore have a Gibbs 
free energy lower than other folding possibilities[34].  
∆𝑔(𝑇) = ∆ℎ(𝑇) − 𝑇∆𝑠(𝑇) 
This Gibbs free energy function is relevant to all thermodynamically controlled reactions, however as 
the entropy of the system cannot be directly measured, it must be expressed in another manner. 
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Privalov [35, 36] shows a method for expressing the Gibbs free energy stability function in terms of 
the denaturation temperature and heat capacity of a protein as follows. 
∆𝑔(𝑇) = ∆ℎ(𝑇𝑑) (
𝑇𝑑 − 𝑇
𝑇𝑑
) − (𝑇𝑑 − 𝑇)∆𝐶𝑝 ln (
𝑇𝑑
𝑇
) 
If this function is then plotted with Gibbs free energy as a function of temperature, we get the specific 
protein stability curve [33] for that protein system (Figure 2-1). 
 
Figure 2-1 A generalised protein stability curve, depicting a region of stability between the critical 
temperature (Tc) and the Melt temperature (Tm) for the protein. Temperatures beyond these points 
will lead to instability of the protein structure. [37] 
As the protein is solubilised into solution, the Gibbs free energy for the system will depend on the 
character of the solution as well as the protein, therefore the stable conformation observed within 
that solution and its characteristic heat capacity and denaturation temperatures will also be a function 
of that formulation.   
Unlike monomeric proteins, the stability of multimeric proteins is closely linked to concentration as, 
by Le Chatelier’s principle, any dissociation which increases overall concentration will push the 
reaction to mitigate this change.  Thus when analysing the stability of a multimer it is crucial to develop 
a series of thermodynamic state functions which take concentration into account[38].  The equilibrium 
constant for the folding/unfolding reaction must be characterised and this is quantified by the Gibbs 
free energy, as the equilibrium position will occur at the free energy minimum[16, 39].  
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𝐾 = 𝑒−
∆𝐺𝑜
𝑅𝑇  
As usual the temperature dependence of the enthalpy change for the equilibrium is calculated using 
the van’t Hoff equation. 
𝜕𝑅 ln𝐾
𝜕 (
1
𝑇)
= −∆𝐻𝑣ℎ 
Note that the calorimetric enthalpy does not equal that of the van’t Hoff enthalpy 
∆𝐻𝑐𝑎𝑙 ≠ ∆𝐻𝑣ℎ 
The heat capacity of the system is also temperature dependant and this must be taken into account. 
∆𝐶𝑃 = (
𝜕∆𝐻
𝜕𝑇
)
𝑃
 
This may be integrated to yield 
∆𝐻(𝑇) = ∆𝐻(𝑇𝑚) + 𝐶𝑃(𝑇 − 𝑇𝑚) 
Note that the melt temperature (Tm) is defined as the temperature where exactly half of the protein 
is denatured. 
It follows that the entropy change for this reaction is  
∆𝑆(𝑇) = ∆𝑆(𝑇𝑚) + ∆CP ln (
Tm
T
)  
Once again yielding the protein stability curve. 
A molecular partition function may be used to quantify the equilibrium position. This is defined as:  
𝑄 =
[𝑁] + [𝑈]
[𝑁]
= 1 +
[𝑈]
[𝑁]
= 1 + 𝐾 
Where: 
Q = The molecular partition function 
K=Equilibrium constant 
[N], [U] = The concentrations of the native and unfolded states respectively 
  
It follows that a fractional population can be constructed for each species as  
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𝛼𝑁 =
1
𝑄
=
1
1 + 𝐾 
 , 𝛼𝑈 =
𝐾
𝑄
=
𝐾
1 + 𝐾
 
The fractional population can then be experimentally measured by quantifying the change in 
spectroscopic signal (S) as the reaction progresses. 
 
𝑆𝑜𝑏𝑠 = 𝛼𝑁𝑆𝑁 + 𝛼𝑈𝑆𝑈 
A spectroscopic signal gives different information to a DSC measurement of the unfolding process.  As 
K (and  αN) is a function of Tm, ∆H(Tm), ∆CP both of these methods can be used to provide this 
information. 
2.1.3.  Irreversible denaturation of proteins 
A method for the analysis of irreversible denaturation occurring under a two state model was derived 
by Sanchez-Ruiz [40].  The model assumes that an irreversible first order transition occurs for which 
the denaturation temperature is scan rate dependant.  These are conditions required under the two 
state model kinetic model of protein denaturation.  It is also assumed that the rate constant [22, 41] 
of the denaturation follows the Arrhenius equation  
𝑘 = 𝐴𝑒𝑥𝑝(−
𝐸
𝑅𝑇
) 
as is expected. 
The applicability of the two state model was tested through analysis of the activation energy for the 
denaturation.  This was done by the mathematical extrapolation of the above conditions when applied 
to the denaturation rate constant, the heat capacity at various scan rates, the heat evolved as a 
function of temperature and the heat capacity at the denaturation temperature. If the two state 
model applies to the measured denaturation these plots will show good agreement to their models 
and the activation energy calculated will agree.   
Firstly the rate constant of the denaturation, assumed to follow the Arrhenius equation, was 
calculated as a function of temperature: 
𝑘 =
𝑣𝐶𝑝
𝑄 − 𝑄𝑡
 
Where 𝐶𝑝 and 𝑄𝑡  are a function of temperature. 
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The data is then plotted on an Arrhenius plot where the slope of the resulting line is equal to the 
activation energy. 
Secondly the heat evolved at any set temperature follows  
ln (ln (
𝑄𝑡
𝑄𝑡 − 𝑄
) ) =
𝐸
𝑅
(
1
𝑇𝑚
−
1
𝑇
)  
Thus the slope obtained from plotting the Left hand side of this equation vs. 1/T will be equal to E/R 
allowing for calculation of the activation energy. 
Thirdly the denaturation temperature will be dependent on scan rate as follows 
𝑣
𝑇𝑚
2 =
𝐴𝐸
𝑅
𝑒 (
−𝐸
𝑅𝑇𝑚
) 
Allowing for the calculation of activation energy from the slope of the plot of ln(v/Tm) vs. 1/Tm. 
 
Finally the activation energy was calculated directly from the heat capacity at the denaturation 
temperature as follows 
𝐸 =
𝑒𝑅𝑇𝑚
2𝐶𝑝
𝑚
𝑄𝑡
 
The initial paper, as well as subsequent publications[42, 43], shows that for any irreversible 
denaturation the two state model, as tested by the above conditions, correlates well with 
experimental data.  This allows for the calculation of useful thermodynamic data from irreversible 
transitions.  Prior to this approaches to calculating the energy associated with denaturation required 
the assumption of reversibility, as per Anfinsen’s experiment, to satisfy the reversible thermodynamic 
model.  As no current study has found a hemocyanin denaturation to be reversible, this method will 
allow for the calculation of thermodynamic data from DSC experiments. 
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2.2. Protein Formulation 
2.2.1. Stabilising and Destabilising Forces 
The stability of a native protein is a function of the Gibbs free energy for the entire system in which 
the protein is solvated. Thus in order to increase the stability, we may either promote interactions 
which increase the strength of bonding within the protein, or increase the energy contribution of the 
solvent towards the native state[3]. A number of approaches have been considered to stabilise 
proteins, generally with the addition of excipients, covalent modification or lyophilisation techniques 
[44, 45]. However, experience has shown that no one approach is effective for all proteins, and a 
separate formulation must be considered for any new protein pharmaceutical[4, 46].. 
2.2.2. Effect of salt concentration on protein stability 
Ionic salts have long been added to protein formulations in order to change their stability. Whilst the 
relative effect of each of the salts changes depending on the structure of the protein in question, the 
general order of stabilising effect remains the same. This was first observed by Hofmeister in 1888, 
and has been widely studied since.[47-50] Whilst the Hofmeister series lays a specific order of 
destabilising to stabilising ions, other contributing effects have been observed such as a specific 
interaction of multiply charged ions with the protein secondary structure [51, 52]. Further, some ions 
including Calcium and Magnesium have been seen to induce aggregation, particularly in unstable 
proteins. [53] 
2.2.3. Effect of sugars on protein stability 
The addition of sugars into a protein formulation has long been considered as a method for stabilising 
the protein with early studies indicating that the denaturation temperature of the protein may be 
increased by as much as 18.5oC [54], yet the exact mechanism by which the stability is increased is yet 
to be determined.  
It was suggested by Arakawa [55] that all stability gains were due to the preferential hydration of the 
protein, however the earlier study by Back [54] suggests that the major contributor to the stability 
increase was through changing the free energy of the water in solution, rather than the energy of the 
protein itself. Benton[56], however, suggests that the stabilisation effect may have an enthalpic 
contribution, instead of a entropic crowding only effect. Likely, both of these energetic contributions 
are at play in the increased stability of the protein as they can both contribute to the free energy of 
the entire system.  
As these theories all involve stabilising interactions, there are no reports of sugar additions 
destabilising protein formulations, however the relative effect of sugars have been reported to vary. 
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Furlan [57] reported that the stability increase for bovine plasma was correlated with the molecular 
weight of the sugar addition, with sucrose performing better than glucose. This would suggest that 
the excluded volume theory was dominant, as the larger sugar was excluded to a higher extent. 
Arakawa[55], however, found that the difference between the stabilising effect of Lactose and 
Glucose were minor, suggesting that this gave evidence that the relative interaction of the sugar with 
water, and not the excluded volume was the dominant force. 
Whilst these theories all suggest that sugars should promote stability proportional to their 
concentration with no limit[58], this has not been observed. A decrease in the protective effect of the 
sugar was identified at above 10 % w/v by Furlan [57] and Arakawa [55]reporting a low dependence 
of sugar concentration on the stabilising effect. Back [54]had earlier suggested this was due to the 
sugar structures formed in solution. If structures such as Micelles were created by the sugars, then 
their relative effect on the free energy of the water would be minimised [59, 60]. 
These studies suggest that whilst sugar additions to a protein formulation will certainly have a 
stabilising effect, the effect of sugar identity, and concentration may not be so pronounced. Further if 
the stabilising effect of the sugar was dependant on sugar size, it would give evidence that the 
excluded volume effect was more pronounced than the free energy change of the water system due 
created by the sugar. 
2.2.4. Protein aggregation forces 
Proteins are often observed to aggregate whenever non-polar sections of protein meet, forming a 
more stable structure as an aggregate than an individual protein. This effect may be measured directly 
by circular dichroism [61] due to the induced changes in folding. Whilst this process may be either 
kinetically or thermodynamically controlled [62], the process is always irreversible, and hence no 
thermodynamic character can be directly measured.  
Photon correlation spectroscopy is the most direct method for observing protein aggregation[63, 64], 
however the resolution of the technique limits its applicability to all but the largest proteins or 
aggregates. Protein aggregates are a problem for protein formulation due to the destructive and 
irreversible nature of their interaction. [65] Protein aggregation may be measured in a number of 
ways, including [63, 66]  
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2.3. Hemocyanin  
 
Hemocyanin is the name given to a class of respiratory proteins which uses a dicopper centre to bind 
dioxygen and transport it through the body.  These proteins are found in the blood of all Arthropods 
and Molluscs.  Whist the primary structure of all hemocyanins shows a high homology, the quaternary 
structure of hemocyanins varies between species and varies dramatically between Arthropods and 
Molluscs[15].  Hemocyanins were first discovered in 1900 [67, 68] however analytical research on the 
structure and properties of hemocyanins began in the 1980s [69].  
 
2.3.1. Structure of hemocyanins 
Molluscan hemocyanins are characteristically composed of subunits of 340-400kDa which are further 
organised into a quaternary structure formed of decamers, or multiples thereof, of identical 
subunits[69, 70].  The individual subunits are single polypeptide chains containing 8 copper containing 
functional units, of which 8 different functional unit structures have been isolated.  In the case of 
hemocyanin from the key hole limpet (the most studied species) this leads to an overall quaternary 
structure of 8MDa.  Extensive articles and reviews exist defining molluscan hemocyanin structures [14, 
15, 70-72]; however these structures will not be considered in detail here.  
The hemocyanin of the Arthropod must also be considered as the quaternary structure of arthropoda 
hemocyanin is vastly different to that of molluscan hemocyanin, which may be manifest in the thermal 
properties of the protein[73].  Arthropoda hemocyanin, whilst containing similar functional and 
subunit conformations to molluscan hemocyanin, creates hexameric quaternary structures. Various 
species form multiples of this with the most common being the hexamer and the dodecamer. 
 
2.3.2. Hemocyanin Stability 
Previous studies have been conducted on the stability of hemocyanin using a variety of techniques, 
namely DSC on the hemocyanin of the Gastropod Rapana thomasiana [74] and  Arthropod Pulinurus 
vulgaris  [43]. Circular dichroism for a variety of arthropoda and mollusca [73], Fluorescence 
spectroscopy for a variety of arthropoda [75] and FTIR for a variety of species[76].  These articles have 
all found the denaturation of hemocyanins to be an irreversible process and have further analysed 
various features of the hemocyanin stability. 
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The earliest study on the thermal denaturation of hemocyanin [43] gives evidence that the 
denaturation of hexameric hemocyanin follows the two state kinetic model of protein denaturation 
implying that the unfolding of the protein at the denaturation temperature is cooperative and 
happens as a single step, as opposed to a denaturation in which several partially unfolded states may 
occur.  Later research[74] confirms this finding using similar methods on dissimilar species.  The 
implication of this is that the vant Hoff equation cannot be applied directly to calculate the protein 
stability curve for hemocyanins. 
The two state model was tested following the procedure of Sanchez-Ruiz [40].  It was observed by 
Guzman-Casado and Idakieva that the denaturation data for hemocyanin closely fitted the above 
mathematical models for the two state model.  Within each paper the calculated activation energies 
were comparable for Guzman-Casado [43] an 𝐸𝑎 = 383 ± 30 𝑘𝐽/𝑚𝑜𝑙 was recorded and for Idakieva 
[74] activation energies of 𝐸𝑎 = 597 ± 20 𝑘𝐽/𝑚𝑜𝑙.  The far higher activation energies in the later 
paper are attributed to the use of molluscan hemocyanin compared with the arthropod hemocyanin 
considered earlier.  This is however in contrast to the following studies which consider the separated 
subunits of both arthropod and molluscan hemocyanin finding no correlation of stability with Phylum.  
It should also be noted that the uncertainty in the activation energy found in these papers is higher 
than expected based on the study which created this method (𝐸𝑎 ± 8 kJ 𝑚𝑜𝑙
−1 ).  One possible 
explanation for the lower certainty found in this paper was proposed to be a second denaturation 
peak existing near the end of the normal thermal denaturation.  Such a peak was observed when 
heating the hemocyanin to its denaturation temperature, cooling it and heating through the 
denaturation.  This method should allow the previously observed denaturation to occur on the first 
heating and any secondary denaturation to follow.  Such a peak was observed 3oC higher than the 
normal denaturation and must be tested for in further thermal denaturation studies. 
It has also been found that the two state model did not accurately describe the behaviour of 
hemocyanin monomers.  A possible explanation for this was suggested to be differences in the 
denaturation parameters for the different subunits found in hemocyanin macrostructures[43]. 
This paper also compares the same calculations for samples of different hemocyanin concentration 
between 0.2-3 mg/mL.  It was found that the denaturation temperature was not correlated with this 
concentration.  This leads to the conclusion that the oligomerization state of the protein does not 
change during the denaturation.  Le’Chateliers principle requires that changes in oligomerization state 
create a concentration dependence of denaturation temperature. 
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Fluorescence spectroscopy has also been utilised in the study of hemocyanin stability[75],however in 
this case no calculation of thermodynamic properties was conducted.  The study instead focused on 
denaturation due to pH and chemical denaturants. It was discovered that the chemical denaturation 
of many hemocyanins followed a multistage denaturation and subsequent aggregation of the 
hemocyanin monomers, a further hypothesis that three chemical denaturation peaks were observed 
due to the existence of three distinct domains in the subunit structure.  Whilst this is a logical 
conclusion, it is in contrast to thermal stability studies which show a two state denaturation [43, 74]. 
It is expected that both chemical and thermal denaturation will follow the same kinetics.   
Circular dichroism was utilised to measure the denaturation temperature of a series of 
hemocyanins[73].  This study confirmed that the thermal denaturation of hemocyanin was irreversible 
as expected.  A series of hemocyanins from both the mollusca and arthropoda phylum’s were then 
compared showing a range of melt temperatures from 65-92oC (covering the range found before[43, 
74]), the melt temperature was not, however, correlated to phylum, suggesting that the quaternary 
organisation of the hemocyanin does not play a major role in the denaturation.  It was also found that 
the denaturation temperature was dependant on oxygen binding with the oxy form having a 
denaturation temperature on average 11oC higher than the Apo form[73].  This implies that for 
reproducibility of results samples must be either homogeneously oxygenated or deoxygenated. 
Finally one study has been performed measuring thermal stability with temperature controlled FTIR 
measurements[76].  This study focussed on the possible effects of glycosylation on the denaturation 
temperature. By studying the hemocyanin functional units separately they were also able to conclude 
that the a range of denaturation temperatures exist for the various functional units (as proposed 
earlier[43]) .  It was also discovered that the effect of oxygenation had a stabilising effect of up to 20oC 
supporting the measurements of [73].  The study, however, did not find any correlation between the 
glycosylation of the functional units and the denaturation temperature.  This was unexpected as a 
correlation between glycosylation and stability had been previously established for other 
glycoproteins. 
It can be concluded, therefore, that studies on the thermal denaturation of hemocyanins have found 
the denaturation to be irreversible and to follow the two state model.  Various hemocyanins display a 
wide range of denaturation temperatures; however there appears to be no correlation between 
quaternary structure or glycosylation on the denaturation temperature.  
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2.3.3. Therapeutic Applications of hemocyanins 
Hemocyanins are considered to be promising candidates for a number of different pharmaceutical 
applications including as antiviral agents, antimicrobial agents and as carriers for anticancer agents. 
These wide ranging applications of hemocyanins make them a prime candidate for therapeutic testing, 
with drug trials well established in some fields. As each of these applications are theorised to utilise 
hemocyanin by different mechanisms, they will be outlined separately. 
One common method for creating cancer vaccines is to conjugate their sugar moieties onto a protein 
in order to induce an immune response to them[77]. Hemocyanin from the Keyhole Limpet (KLH) has 
frequently been used as a carrier protein for this purpose. KLH was found to elicit one of the strongest 
immune responses of the possible carriers tested, making it a viable conjugation option[78, 79]. 
Hemocyanins from three different species have been considered for their antiviral activity, Penaeus 
Monodon [9], Rapana Thomasiana [80] and Haliotis Laevigata [81]. Whilst Zhang[9] and Genova-
Kalou[80] both provide evidence that whole hemocyanin protein has strong antiviral activity against 
white spot syndrome virus and herpes simplex 1 and 2 viruses respectively, Dang [81] instead suggests 
that it is the sugars and small peptides in the hemocyanin hemolymph sample instead which provide 
the antiviral activity they measured (towards herpes simplex 1 virus). 
There is also some evidence that hemocyanins perform an antiviral function within their organism 
[82], possibly exhibiting enzymatic activity and conversion to phenoloxidase to fight infection [83]. 
This may explain the antiviral effects observed from hemocyanins in vivo. 
Arancibia [84] has also suggested that the immunostimularory effects of hemocyanins were limited 
by a lack of stability, highlighting the importance of creating a stable hemocyanin for pharmacological 
testing. Whilst the current studies into hemocyanins therapeutic value paint an incomplete picture of 
the medicinal potential for hemocyanins, it is clear that hemocyanins possess some drug activity and 
as such are worth studying in greater depth.  
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CHAPTER 3. Physical Characterisation of Hemocyanin 
 
Hemocyanin from Haliotis Rubra was obtained as uncharacterised blood sera from Haliotis Rubra 
abalone. Whilst previous research and anecdotal evidence had identified some potential therapeutic 
activity of the sera, particularly towards the mouth borne herpes simplex two virus, no evidence was 
yet available on what components of the blood sera had this activity. It was also entirely unknown 
whether any active compounds could be separated from the sera whilst retaining their stable active 
states.  
Previously published research on the blood of Molluscs suggested that the major protein component 
of the sera would be a hemocyanin, and whilst it was certain that the sera contained hemocyanin, the 
concentration of that hemocyanin could not be assumed. Further, any research into the properties 
and stability of the hemocyanin content would require an investigation into the physical properties of 
the protein as it is already established that these properties vary greatly depending on the species 
from which the hemocyanin was derived. Haliotis Rubra hemocyanin has not previously been 
investigated in the literature, and as such this will be the first work to assess it. In this chapter the core 
physical properties of Haliotis Rubra sera, and its contained hemocyanin are investigated. 
As few contemporary protein samples have been obtained by purification from animal sources and as 
the hemocyanin protein was expected to have an extremely high molecular weight, we have 
investigated various purification and identification methods which are not commonly used in current 
molecular biology[85]. The large size (high molecular weight) of the  presents many challenges, 
including low permeability of the protein into PAGE or IEF gels, diffusion properties more resembling 
suspended particles than dissolved proteins, rapid aggregation of large protein quaternary structures 
and the use of computer models which assume that all proteins have a lower molecular weight than 
hemocyanin.  
This chapter will discuss the challenges associated with first purifying Haliotis Rubra hemocyanin from 
blood sera, how to measure purity when standard gels are not designed for proteins over 500 kDa, 
identifying the closest available homologous hemocyanins using mass spectrometry and how to coax 
methods usually used for suspended particles into the analysis of protein size and charge. 
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3.1. Hemocyanin Sera 
Sera containing the blood extracted directly from live adult Haliotis Rubra abalone was delivered to 
our labs in 1 L bottles from Marine Biotechnology Australia in Hobart. The first challenge with this sera 
was identifying suitable sterilisation and purification methods for a protein of exceptional size. The 
deep blue colouring of the sera indicated that a large quantity of hemocyanin existed in solution, 
owing to the dicopper centres used for oxygen transport in hemocyanins.  
The sterilisation and purification of small proteins is a relatively simple task, however the expected 
size of hemocyanin protein required careful planning, particularly to avoid filtering out or denaturing 
the protein during this task. 
3.1.1. Purification methods 
Hemocyanin sera samples were first sterilised through a 0.22 µm filter cartridge and separated into 3 
mL aliquots for storage at 4oC.  Individual samples of purified hemocyanin were then prepared by 
isolation over a 100 kDa Amicon filter tube.  
The buffering solutions to be used for the hemocyanin samples were prepared, by dissolving the given 
concentration in MilliQ water, and chilled to 4oC. For initial testing 100mM TRIS buffer was applied. 
The 3 mL of hemocyanin sera was placed into the Amicon tube and centrifuged at 4000 rpm at 4oC for 
20 minutes resulting in a retentate of ~0.5 mL expected to contain the hemocyanin protein. The 2.5mL 
of filtrate, expected to contain no hemocyanin, was either retained for analysis or discarded.  The 
retentate was then diluted to the original 3 mL with cold buffer and centrifuged again.  This was 
repeated five times to increase the purity of the retained proteins.  The final product was expected to 
contain material between 0.22µm and approximately 100 kDa within the chosen buffer solution.  This 
was then analysed for purity, protein concentration, final pH and visually inspected for large 
aggregates before storage at 4oC. 
3.1.2. Protein concentration and purity 
The protein concentration and the purity of any proteins within the sample were required for 
validation of any subsequent analysis. Protein concentration was calculated using the Qubit 2.0 
Fluorometer system, from ThermoFisher Scientific, according to its specified instructions and 
reagents.  This method had previously been validated against the Bradford Assay within our research 
group by Dr Yan Er. 
Protein purity was determined by both native and denaturing gel electrophoresis methods in precast 
Invitrogen gels. For denaturing PAGE, a 3-8% Tris-Acetate gel was used as it was the largest porosity 
gel available. For native gels, the blue native Bis-Tris kit was applied.   
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3.2. Hemocyanin size 
Hemocyanin, a protein family containing some of the largest proteins ever discovered, poses many 
difficulties for the application of standard protein analysis methods, including but not limited to 
electrophoresis, FTIR and Circular Dichroism methods, which rely on the diffusion, solubility and 
mobility of the protein and have been optimised for the analysis of much smaller proteins such as 
albumin. Thus, before utilising any standard methods for the analysis of hemocyanin, we must first 
validate their applicability to this protein.   
We are presented, however, with an opportunity to apply techniques usually inaccessible to proteins, 
particularly those based on the diffraction of light through soluble samples, as the sheer size of the 
protein may give diffraction patterns more similar to suspended particles than those of mobile 
dissolved proteins. In particular the quaternary structure of a protein as large as Haliotis Rubra 
hemocyanin will become large enough to be detected by their scattering patterns. 
This chapter discusses the methods we have discovered for the investigation of the size of hemocyanin 
and the related challenges posed to conventional technologies.  
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3.2.1. Gel electrophoresis  
Conventional methodologies require the application of gel electrophoresis to determine the size and 
purity of any protein solution.  This includes the use of standardised protein solutions to calibrate the 
distance of travel to the size of the protein, however as no commercial standards include a protein as 
large as hemocyanin, the data had to be interpolated to the size of the protein. 
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Figure 3-1 Gel electrophoresis of Haliotis Rubra hemocyanin showing the protein stuck in the stacking 
section. Lanes 1-5 and 6-11 all contain 20µg purified hemocyanin, run simultaneously to test 
resolution, L is a broad range ladder (6.5-200kDa)   
 
Figure 3-1 shows a standard BIS-TRIS SDS PAGE gel, of the largest available porosity, containing 
hemocyanin and a BioRad broad range molecular weight ladder (6.5-200kDa). The bunching of the 
hemocyanin at the top of the gel indicates that the protein was too large to enter the pores of the gel 
and has instead stuck into the stacking section of the gel. Other gel systems, such as the Blue Native 
system, utilising larger porosity gels and different staining systems were then investigated. 
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Figure 3-2 BlueNative Gel showing Hemocyanin separated into two distinct protein bands. Lanes 1-3 
are 20µg pure hemocyanin, L is a NativeMark Ladder, Lanes 5-6 are hemocyanin sera, Lane 7 is the 
purification filtrate and lane 8 is a sera sample stored for 3 months.  
The Invitrogen BlueNative system gel in Figure 3-2 allowed for a penetration of hemocyanin into the 
gel and a separation of two distinct bands from the protein sample. Both of these are of larger 
molecular weight than the NativeMark protein ladder, with a largest band of 1236 kDa, indicating that 
these bands must both be multimers of hemocyanin, potentially the decamer and didecamer. 
    1      2     3     4     5     6     L            
 
Figure 3-3 BlueNative gel showing overloaded hemocyanin to check purity. Lanes 1, 4, are purified 
hemocyanin at 200µg, 100µg respectively, showing minor bands at lower molecular weight. 
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Figure 3-3 shows a gel then run with a heavily overloaded sample of hemocyanin in order to determine 
if impurities exist in the sample. This leads to a primary band which is thick and has poor resolution, 
however if any impurities exist in low concentration they will be magnified by the increased sample 
size. Whilst it is not possible to discern impurity bands in the normally loaded sample, the overloaded 
sample shows many distinct bands, indicating some impurities. Of more interest, however, are two 
strong bands which form on either side of the 720 kDa ladder band, as these may be the individual 
hemocyanin subunits. 
Gel electrophoresis, whilst not able to determine any quantitative data about the hemocyanin, owing 
to its large molecular weight, has shown us that the filtered hemocyanin product predominantly 
contains an extremely large protein, almost certainly a hemocyanin, which may be separable into 
smaller units. The purity of this sample was found to be high, considering its source as a blood sample. 
We now have a starting point with which to study the hemocyanin directly.  
 
3.2.2. Photon Correlation Spectroscopy  
In order to assess what conformational structures exist within a formulated hemocyanin sample we 
wished to analyse the size of the suspended protein directly. If the sample was large enough to 
investigate by optical methods, as we anticipate, then this would allow a direct, simple and powerful 
way to directly assess whether the hemocyanin in a sample existed as subunits, larger quaternary 
structures or as aggregates in the formulation we prepared.  
Photon correlation spectroscopy was utilised, through a Malvern Zetasizer 2000 to measure the 
physical size of suspended molecules within Haliotis Rubra hemocyanin sera. As the complete 
hemocyanin itself was expected to have a diameter above 10 nm, it was expected that the protein 
would be observable by PCS.  
Immediately prior to testing, hemocyanin sera, of previously determined concentration (tested by the 
Q-Bit method), was diluted into water in concentrations between 0.01–1 mg mL-1 and placed in PCS 
cuvettes. As a measure of true sample diameter, the Z-average measure was used as per 
manufacturers instruction as it corrects for over representation of large particles. The diameter of 
particles was tested with samples prepared in triplicate, and the composition of each sample also 
measured in triplicate to allow for identification of erroneous results (often observed due to dust 
contamination).  
Whilst samples of each concentration within the above range gave similar results, samples of 0.1 mg 
mL-1 showed the lowest polydispersity and highest repeatability of the sample. As it is standard 
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practice to tune the output of the zetasizer to the best performing concentration, all further samples 
were prepared at 0.1mg mL-1. 
 
Figure 3-4 Diameter of particles observed in Haliotis Rubra hemocyanin sera. The principal peak at 
44nm is assigned to the hemocyanin quaternary structure 
 
Samples of sera filtered into MilliQ water (pH7.0), Figure 3-4, show that a Z-average diameter of 44 
nm. This is similar to the expected size of hemocyanins from other abalone species, and as such it is 
assigned to the whole quaternary structure of the hemocyanin. Experiments were performed using 
the default Malvern settings, with distribution calculated using the Z-average calculation. This size was 
confirmed for samples of hemocyanin filtered into water and various buffers and concentrations with 
a Z-average diameter of 43 ± 3 nm. 
Samples were then retested after sitting at room temperature and at 85oC for 10 min to determine 
what aggregation states existed. 
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Figure 3-5 Diameter of particles in hemocyanin sample after 10 min at room temperature or 10 min at 
85oC 
 
It was found that after only 10 min in pure water, hemocyanin had begun to aggregate noticeably, 
with a prominent peak forming at approximately 1000 nm. After treatment at 85oC aggregates at 500 
nm and over 2000 nm were observed. Determining the accurate size of the aggregates proved difficult 
as repeat testing yielded constantly changing values. This was expected due to the continuing 
aggregation process and hence constantly changing particle size.  Further, due to the large mass and 
low count of large aggregates, they are poorly measured by dynamic light scattering.  Whilst this 
makes determining exact aggregate size impossible, the identification of aggregation behaviour was 
none the less determined. 
It was found therefore, that testing of hemocyanin particle size via the zetasizer was a reliable method 
for determining if a hemocyanin sample had aggregated, or if it was in its native state. This method, 
whilst very effective, is not commonly used to study protein conformations as it can only pick up 
proteins above 10 nm in diameter. Thus dynamic light scattering methods have allowed an adapted 
method for studying hemocyanin usually reserved for suspended particles. 
This PCS method for monitoring hemocyanin aggregation is a rapid and effective way to study the size 
of aggregates within the sample. Whilst it is not widely applicable to protein aggregation studies, due 
to the required minimum particle size, we have found it to be a viable method for proteins as large as 
hemocyanin.   
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3.3. Hemocyanin Subunits 
Whilst hemocyanin naturally forms into large didecameric quaternary structures, these structures are 
composed of individual single chain subunits which themselves have folded structures. Revealing the 
properties of these individual subunits would yield insights into the degree of stability afforded by the 
tertiary and quaternary structures as well as allowing us to probe the stability and potential 
therapeutic effects of individual subunits as well as the whole hemocyanin. 
Whilst many possible candidate methods may be able to separate hemocyanin into its subunits, most 
of these methods, including chemical denaturants, temperature and enzymatic lysis would be 
destructive of the folded structure of the hemocyanin. One candidate method, however, presents as 
potentially non-destructive, treatment in alkaline pH. 
To test if alkaline pHs could separate hemocyanin subunits, samples of hemocyanin were dialysed into 
glycine buffers with pHs ranging from 8-10.  The first and fourth and seventh bands of Figure 3- show 
hemocyanin in pHs of 9 10 and 11 respectively, with the two bands following each high pH sample 
being the initial sample and the protein after being returned to neutral pH.  
              1          2              3     4            L           5            6        7              8           9  
 
Figure 3-6 Blue Native gel comparing purified hemocyanin in neutral buffer, with high pH separated 
hemocyanin subunits. Bands 1, 4, 7 show hemocyanin at pHs of 9, 10 and 11 respectively, with the two 
bands following each high pH sample being the initial sample at neutral pH and the protein after being 
returned to neutral pH. 
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As it can be seen the high pH samples have dissociated from their large molecular weight band. The 
marker in lane five shows a band of 720kDa between the two separated subunit bands, showing that 
the molecular weights of the two subunits must be on either side of this size.  
In order to verify the size of the proteins in the high pH samples, we tested them with the zetasizer 
procedure first used to determine whole hemocyanin diameter. 
 
Table 3-1 Comparison of measured diameters and volumes of whole and subunit hemocyanin 
 Whole Subunits 
Z-average diameter (nm) 43 20 
Volume (nm3) 41600 4200 
Ratio of volumes  9.9 
 
As the ratio of volumes observed for the hemocyanin and its subunits are almost perfectly 10, there 
is a high probability that we have observed whole hemocyanin separating into dimers in the 
formulated sample. 
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3.4. Homology of Haliotis Rubra hemocyanin to hemocyanin of other 
species 
Blood sera from the black lipped abalone (Haliotis Rubra) has been studied via mass spectrometry to 
determine the composition of the proteins it contains.  Electrophoresis was first performed on the 
sera to isolate the proteins from the sample.  The high molecular weight bands were then treated via 
a tryptic digest and tested via mass spectrometry to compare their structures to published genome 
sequences.   
It was found that each of the bands tested were composed of hemocyanin or hemocyanin fragments.  
Whilst it was expected that the largest proteins in the sera must be hemocyanins, this data has 
provided the first confirmation of this hypothesis.  The data also suggests that the other bands 
separated by electrophoresis are the result of hemocyanin degradation as opposed to sample 
impurities.  Hemocyanin from the European green ormer abalone (Haliotis Tuberculata) has been 
identified as the most homologous protein to those measured, with further similarity to other abalone 
species found.  Only a low homology to that of the more widely studied keyhole limpet was identified. 
Whilst it is simple to collect indirect evidence that we are working with hemocyanin, such as an 
extremely large size, copper content and resulting blue appearance, proving protein identity requires 
identification of the primary structure. This is traditionally performed either by a direct Edman 
sequencing of the amino acid residues or matching of a protein to a part of the complete genome for 
the species.  As the genetic sequences for a number of molluscs have been published, we have chosen 
to look for genetic matches for this protein through the use of mass spectrometry.  
Whilst the genome sequence for Haliotis Rubra has not been studied, the sequence for coding 
hemocyanin in a number of other abalone species has been recorded.  As the shape and size of the 
protein are similar to those for the hemocyanin from other mollusca, it is assumed that a highly 
conserved sequence exists and the homology between the proteins will be high. This will be tested by 
the level of overlap measured for our hemocyanin and that from these other species.  
A series of sera samples from the abalone were prepared, including a purified hemocyanin sample, 
hemocyanin subunits, prepared in a pH 8.5 glycine buffer and raw hemocyanin sera samples.  These 
samples were then purified by blue native gel electrophoresis to yield distinct pure bands.  After fixing 
of the gel, the intact protein was immobilised in the gel and the individual bands were cut.  Each band 
sample was then further purified to remove any unwanted salts or impurities.  The bands were then 
individually treated with trypsin to fragment the protein.  The resulting small peptides were released 
from the gel due to their low molecular weight. The individual peptide mixtures from each band were 
then taken to mass spectrometry.  An LCMS used to separate and identify the individual peptides 
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within each sample.  These were then charged and accelerated within an electric field.  The time of 
flight was measured to determine an accurate mass of each observed peptide.  
For each band, dozens of small peptide fragments were observed. As these fragments often 
overlapped, possible larger sequences could be derived. The protein database “MASCOT” was used to 
identify the protein primary structures which could yield the observed peptides.  Each peptide mass 
was compared to the database individually.  Many of these peptides would be common to a series of 
proteins, however some will be unique.  The potential protein matches which could yield a significant 
number of the observed peptides are then tabulated and presented to the user as an identification 
tool. 
Further to this, the database “BLAST” was then used to determine homology between proteins.  In 
this case it is used to determine the level of homology between each of the hemocyanins which have 
previously been published.  
Gel electrophoresis was conducted on a series of hemolymph samples.  This included samples which 
were purified and unpurified as well as samples which had been treated at pH 2 and pH 10.5 before 
purification.  As can be seen in Figure 3-7 below, all bar the base treated samples (lanes 5 + 6) are 
extremely similar.  
The base treated samples, however, show a series of new bands and a disappearance of the extremely 
high molecular weight bands.  Similar observations have been made for other hemocyanins, in which 
base treatment leads to a separation of the quaternary structure into subunits. Two distinct bands 
form at approximately 400 kDa and it is hypothesised that these may belong to two different isoforms 
of the hemocyanin subunit, as is the case for some hemocyanins.  
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Figure 3-7 Gel used for the LCMS of Haliotis Rubra hemocyanin. Individual bands, as labelled, were 
cut and treated for LCMS. 
From the gel electrophoresis a total of nineteen individual bands were chosen to be cut and treated, 
the bands which were then taken to mass spectrometry are labelled.  It was expected that the larger 
molecular weight bands may be hemocyanins and the lower molecular weight bands may be 
impurities or fragments.  The chosen bands were chosen to provide a wide variety of molecular weight 
bands. 
The following table illustrates that a MASCOT search identified a hemocyanin as the most likely parent 
for the measured peptides in every sample.  The first isoform of hemocyanin from Haliotis Tuberculata 
[86, 87]was measured as the most homologous protein to the sample in every case, where results are 
ranked on their matching score.  A score above 100 is considered a positive result and due to the 
exceptional size of hemocyanins, very high scores could be attained.  It is also useful to look at the 
number of protein sequences which were directly matched which in most cases is over twenty distinct 
peptides.  The number in brackets indicates how many of these sequences are unique to the protein.  
The total coverage, also documented for comprehensiveness, is less significant as a high coverage 
would never be achieved for such a large protein and in particular one where the species is not directly 
matched from the database. 
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Table 3-2: MASCOT fits of individual bands separated from hemocyanin PAGE 
Band # Hemocyanin from species 
identified 
Matching 
score 
# 
sequences 
Coverage 
% 
3 
Haliotis Tuberculata 
Haliotis Diversicolor 
832 
462 
18(9) 
9(5) 
4% 
2% 
6 
Haliotis Tuberculata 
Haliotis Diversicolor 
2133 
1284 
47(22) 
28(15) 
9% 
5% 
13 
Haliotis Tuberculata 
Haliotis Diversicolor 
894 
537 
20(8) 
11(5) 
5% 
3% 
8 
Haliotis Tuberculata 
Haliotis Diversicolor 
2323 
1451 
52(19) 
32(13) 
12% 
8% 
9 
Haliotis Tuberculata 
H2 Haliotis Tuberculata 
1635 
1109 
36(15) 
21(12) 
8% 
6% 
10 
Haliotis Tuberculata 
Haliotis Diversicolor 
950 
646 
22(10) 
16(6) 
5% 
3% 
11 
Haliotis Tuberculata 
Haliotis Diversicolor 
724 
558 
20(3) 
14(3) 
4% 
3% 
12 
Haliotis Tuberculata 
Haliotis Diversicolor 
855 
657 
21(7) 
15(5) 
4% 
3% 
 
It is notable that whilst a strong homology is found to various species of abalone, a much weaker 
homology is identified for other molluscan hemocyanins such as that of the keyhole limpet.  It was 
also found that for the highly homologous species, the Haliotis Tuberculata and the Haliotis 
Diversicolor, two different isoforms were documented.  Whilst most of the measured bands were 
positive for isoform one band nine (corresponding to a lower molecular weight band of base treated 
sample) was much stronger in its identification of isoform two.  Whilst isoform one was still present 
in this sample, it is highly likely that the lower molecular weight bands have been concentrated in a 
second isoform of the hemocyanin. 
As we are searching for hemocyanin matches to a similar but not identical species to Haliotis Rubra it 
is expected that some amino acid residues will have been modified through the evolutionary processes 
since the divergence of the two species.  MASCOT is equipped to search for such modifications by 
specifying only one protein match to the sample and researching for specific masses associated with 
possible modifications. This method has allowed us to propose a series of potential amino acid 
substitutions based on observed residue masses which would match a divergent search.   
In one case, utilising divergent search results suggested 27 single amino acid substitutions, increasing 
the score and coverage by more than double.  Similar results were indicated for other bands and these 
results indicate a high probability that substitutions have occurred.  A mapping of the Haliotis Rubra 
genome would be necessary in order to confirm this hypothesis. 
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In order to support the hypothesis that amino acid substitutions were possible a BLAST search was 
performed on the most homologous hemocyanin, Haliotis Tuberculata.  In this case the known 
sequence for Haliotis Tuberculata hemocyanin was compared only with other published structures.  
This revealed that over 60% of the protein sequence was conserved within the abalone family.  
Sections of the structure were also observed for other hemocyanins; however the similarity was much 
lower.  This explains why the overlap between our hemocyanin and other abalone hemocyanin is high, 
whilst the overlap with other mollusca is low. 
This experiment has given the first hard evidence that we are indeed studying a hemocyanin and that 
the primary structure of it is highly similar to that of Haliotis Tuberculata.  The increased homology 
between our sample and other abalone, and the low homology to other families indicates that the 
properties and structure of the protein may be conserved within the abalone family; however the 
properties may be vastly different to those observed for other species such as the keyhole limpet.  
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3.5. Hemocyanin Charge 
The charge on the protein determines its aggregation behaviour, and is based primarily on the charge 
of the amino acid residues which make up the protein.  This can be estimated from the primary 
structure or measured directly.  Proteins will readily form aggregates when in a solution with a pH 
near their isoelectric point (pI) as the net charge on their surface will be close to zero and hence there 
will be no charge repulsion.  At pHs away from the proteins pI the protein molecules will all have like 
charge, and hence will repel, reducing the aggregation driving forces. 
Standard protein protocols call for measurement of the isoelectric point using an isoelectric focussing 
gel (IEF) often accompanied by a theoretical determination of the pI calculated from the sequence of 
the protein. However for Haliotis Rubra hemocyanin these methods will prove problematic as the size 
of the protein may inhibit migration of the protein within the IEF gel, as has occurred for PAGE gels, 
and the sequence of the protein is unknown. We therefore have considered techniques usually used 
for larger charged particles in order to determine the net charge on the hemocyanin and hence 
approximating its isoelectric point. The two most promising options were an auto titration of the 
protein and the measurement of its zeta potential in solutions of changing pH. 
 
3.5.1. Isoelectric Focussing  
The charge on small proteins is generally measured using an isoelectric focussing gel electrophoresis 
technique in which a gel is cast in which has a pH gradient. The protein will then migrate through the 
gel to the point where the pH of the gel is equal to the pI of the protein.  
IEF gels were run on the whole protein, denatured protein and pH separated subunits of the protein 
to investigate if it were possible to get hemocyanin to travel through any IEF gels. Figure 3-8 shows 
the gel images obtained from IEF gels of the hemocyanin in each of its states. 
 
 
 
Figure 3-8 IEF gels from Haliotis Rubra hemocyanin, showing no separation of hemocyanin through 
the gel 
 
Whilst IEF gels have been specifically cast for large proteins such as hemocyanin [88] it can be seen in 
Figure 3-8, unfortunately, that no states of the protein could enter the IEF gels and as such a clean pI 
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for the protein could not be found from this method. Whilst this means we had to rely on less 
commonly used titration and zeta potential methods for the determination of hemocyanin isoelectric 
point. 
3.5.2. Titration Methods 
An alternative method for establishing the pI of the protein is to titrate the protein solution across its 
possible pI range to identify titration end points which would correspond to protein pIs. Extremely 
sensitive titration equipment has been developed for such titrations including the Metrohm Titrando, 
which was used for this purpose. 
 
Figure 3-9 Titration of Haliotis Rubra hemocyanin with HCl from pH 7 to pH 2 
 
Whilst the raw data shows no obvious titration end points, the first derivative of the titration curve 
can be used to determine if any hidden points of inflexion are present.  In this case we see two 
prominent inflexion points, at pH 3.05 and pH 5.97.  
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Figure 3-10 First derivative of the titration curve for Haliotis Rubra hemocyanin 
The two separate inflexion points in this titration indicate that there were two different pHs at which 
the protein could be ionised. Either may be the pI for the protein; however both may be problematic 
for the stability of the hemocyanin. 
3.5.3. Zeta Potential Methods 
If a protein, or any other suspended material in a solution, is charged it will migrate when placed 
within an electric field and by measuring the rate of this migration the net charge can be calculated. 
For proteins, the surface charge will depend on the pH of the containing solution, such that when the 
pH of the solution is equal to the pI of the protein there will be no charge on the protein. A Malvern 
Zetasizer was therefore used to measure this effect, as was analysed by the zeta potential measured 
by the machine. The pI point (at which no surface charge exists) is therefore equal to the solution pH 
where there is a zeta potential of zero. 
Hemocyanin solutions were created in dialysed buffers at pHs from 3-7 at the optimal concentration 
of 1mg/mL and their zeta potential was measured in triplicate. Whilst the data required that multiple 
buffers be used to cover the entire pH range, the overlaps of these different buffer systems showed 
that their measured zeta potentials were comparable. 
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Figure 3-11 Zeta potential of Haliotis Rubra hemocyanin as a function of pH 
Figure 3-11 shows the aggregated zeta potential data for Haliotis Rubra hemocyanin from pH 3-7 over 
which the isoelectric point of the protein was crossed. The highly positive zeta potential of the 
hemocyanin in acidic conditions indicating a positive charge on the protein. Correspondingly a 
negative charge was observed at pHs close to neutral.  The pI of the protein was determined to be 
between 4.8 and 5.0. Other hemocyanins previously been reported to have a pI range (4.4-5.5 [89]) 
which is consistent with this data. 
This is consistent with titration data suggesting possible pI points at pH 3.05 and 5.97. Considering the 
much more extensive literature supporting the use of zeta potential to measure protein isoelectric 
points, the zetasizer data is preferred over the Metrohm titration data. This suggests a Haliotis Rubra 
hemocyanin isoelectric point of 4.9. 
We have determined the Haliotis Rubra isoelectric point as 4.9. This is the pH at which there will be 
no net charge on the protein. At this pH the protein molecules will not electrostatically repel each 
other and therefore protein aggregation will be rapid. As there is also some evidence, from the 
Metrohm data, that other titration points of no charge exist at 3.05 and 5.97, these pHs may also 
result in increased aggregation and as such any acidic conditions with a pH 6 or below should be 
avoided when formulating this protein.  
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3.6. Conclusions 
 
Chapter three has investigated the physical properties of Haliotis Rubra hemocyanin. Whist these 
properties are simple to derive for most proteins, the extreme size of hemocyanins has made the 
measurement of any physical properties challenging. However, in order to further study the stability 
of this complex protein, we must have an accurate understanding of its size, composition and charge. 
When the protein was purified from a blood sample, over a 100 kDa filter, the remaining sera was 
found to contain almost exclusively hemocyanin. By use of electrophoresis and dynamic light 
scattering we identified that this protein forms a single folded structure of 43 nm in diameter. By 
comparing the primary structure in LCMS we then determined that the composition of the protein 
was most similar to that of Haliotis Tuberculata, indicating that a subunit size of 370 kDa and a 
quaternary structure of 7.39 MDa. The hemocyanin was also found to have an isoelectric point of 4.69. 
The key characteristics of Haliotis Rubra hemocyanin, as determined in Chapter3, are summarised in 
Table 3-3 below. 
Table 3-3 Key physical characteristics of Haliotis Rubra hemocyanin 
Diameter of native protein 43nm 
Molecular Weight 7.39 MDa 
Isoelectric Point 4.69 
Diameter of Subunit 20nm 
 
In this chapter we have investigated properties and techniques which are rarely applied to modern 
protein science. This was necessitated by the sheer size of the hemocyanin and also the source, as it 
is rare in modern protein science to purify proteins from blood sera (with recombinant methods now 
preferred). Whilst this is less convenient than expressing the protein recombinantly, it does allow us 
to investigate a protein sample which may not be possible to obtain any other way. The size of this 
protein, however, has allowed us to use photon correlation spectroscopy methods to assess 
aggregation which are not generally available to protein science and these may be widely applicable 
to the study of extremely large proteins. 
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CHAPTER 4. Characterisation of hemocyanin stability 
In order to create a formulation of Haliotis Rubra hemocyanin with improved stability, we must first 
define how the stability of our hemocyanin formulation will be assessed and then create a baseline 
stability of the protein with which to compare the formulated samples to. As the application of the 
hemocyanin will be as a liquid pharmaceutical product, we have defined the stability against those 
required for the pharmaceutical. Namely, that it must remain in its active form during storage at room 
or fridge temperature for a period of up to two years. 
 
Whilst other researchers in our group will be able to assess the efficacy of the protein as a 
pharmaceutical, directly relating these results to the stability of the formulation may introduce 
unexpected variables into the measurement. It is worthwhile, therefore, to first measure the stability 
of the protein against more conventional biochemical measures, particularly the retention of its 
normally folded, non-aggregated state. 
 
Measuring the size of a hemocyanin molecule, as well as any aggregated protein, was examined in 
Chapter Three utilising dynamic light scattering methods. However, in order to determine under what 
conditions aggregation occurs we will have to extend this method to measuring the onset and progress 
of the aggregation process. 
 
Assessing the folded state of the protein, however, is possible by a number of techniques including 
differential scanning calorimetry (DSC), circular dichroism (CD) and Fourier Transform Infrared 
Spectroscopy (FTIR). Of these, we have focussed on utilising DSC due to its extensive use in the 
measurement of protein folding. Further, whilst we have made many attempts to apply CD and FTIR 
to create comparative results during our study, the rapid aggregation of the hemocyanin during the 
experimental procedure has overshadowed any data we may have obtained from these techniques. 
The thermal stability of hemocyanins from some other organisms has already been studied with DSC, 
providing an approximate indication of the expected thermal stability of Haliotis Rubra hemocyanin. 
Crucially these hemocyanins were all found to denature irreversibly, which would indicate that not 
only the unfolding temperature, but also the rate of that unfolding reaction were measures of its 
stability. 
 
In this Chapter we will define and assess the stability of unformulated hemocyanin and establish 
methods for the investigation of hemocyanin stability which may be applied to other formulations and 
potentially other large proteins for which measuring stability may also be challenging.   
41 
Gavin Marshall PhD Thesis 
4.1. Evaluation of DSC equipment for the study of hemocyanin 
denaturation 
Selection of an appropriate DSC is an essential step in obtaining accurate and reliable experimental 
results, particularly with a protein prone to aggregation. Many potential DSC machines are available 
options for measuring calorimetry traces and three (the TA Q2000, Setaram µDSC3 and the TA 
nanoDSC) were tested for use with hemocyanin. As Haliotis Rubra hemocyanin is anticipated to 
undergo a complex denaturation high resolution may be needed to isolate individual transitions. 
Further, as the denaturation is likely accompanied by aggregation, we must be able to distinguish the 
energy due to aggregation from that due to denaturation. 
 
These three DSC machines cover the range of equipment available in Australia. A trace of the typical 
data from each machine is included as well as some key data from it. Figure 4-1 shows the trace from 
a TA Q2000 series coin cell DSC. A constant ramp rate of 2oC was applied to the liquid hemocyanin 
sample in the heating direction only, delivering the trace in Figure 4-1. These machines are among the 
most common DSC instruments available and are most commonly used to investigate synthetic 
polymers. 
 
Figure 4-1 Haliotis Rubra hemocyanin DSC trace in TA Q2000 
 
This equipment is based at the University of Sydney and is primarily designed for testing solid materials 
packed into disposable cells. Special high pressure hermetic pans were used to test a 70% by mass 
sample of hemocyanin in water, the lowest concentration detectable in the trace. As this setup is not 
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designed for aqueous samples resolution is poor and one large peak is observed from 65-85oC covering 
multiple possible transitions.  
 
A 2010 uDSC3 evo machine from Setaram instruments was then tested. This machine is based at 
LaTrobe University and utilises removable 1 mL hastelloy pressure cells for sample holding. Sample 
concentrations from 1-10 mg/mL were used to identify the sharpest signal. It can be seen in Figure 
4-2, that three transitions are being recorded, two fine peaks and one broad trough. In this case the 
peak position of the 71.3oC peak was found to be heavily scan rate dependant, and the peak at 76.5 
oC corresponds best to peaks observed in other apparatus.  Recent research[53, 65] has suggested 
that using various adjuvants may reduce aggregation effects and hence may reduce the broad trough 
and change the temperature dependence of the small peak. The sharpness of the peaks obtained, 
however, shows the high resolution of the machine. 
 
Figure 4-2 DSC trace for hemocyanin in Setaram uDSC3 evo 
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Finally the TA nanoDSC has been tested extensively. This is a relatively new machine (it was produced 
in 2012) with inbuilt capillary cells designed specifically to reduce aggregation effects in denaturing 
proteins. This machine is based at the University of New South Wales.  
 
Figure 4-3 DSC trace for hemocyanin in the TA nanoDSC 
 
It can be seen from these three spectra that whilst the earlier Qseries does not yield suitable data for 
protein analysis, both the uDSC3 and the nanoDSC yield good calorimetric traces, containing obvious 
peaks which are easily deconvoluted. Whilst the resolution on the Setaram µDSC 3 was the sharpest, 
the ability of the nanoDSC to avoid aggregation during the denaturation reaction may allow more 
viable results.  The core data from these is summarised in Table 4. 
Table 4-1 Comparison of resolution for three common DSC machines. 
Equipment used Peak 1 Peak 2 Width of peak 
TA Qseries 2000 73oC - 11oC 
Setaram uDSC3 evo 76.5oC 71.3oC 5oC 
TA nDSC 75.8oC 81.2oC 7oC 
 
As the TA Q-series DSC provided poor resolution and the SETARAM µDSC showed protein aggregation 
during denaturation, the TA nanoDSC was found to be the most suitable DSC for measuring the 
denaturation of hemocyanin and will therefore be used for future investigations.  
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4.2. Analysis of irreversible denaturation 
With the TA nanoDSC we then attempted to optimise the conditions, testing procedure and data 
analysis for Haliotis Rubra hemocyanin. As this was one of the first experiments done with the 
machine, and the first utilising large proteins, this experiment served as a validation of the equipment 
as well as the methods. 
As analysis of denaturation data depends on the reversibility and order of the denaturation reaction, 
we first had to establish the irreversibility and concentration dependence of the transition in order to 
choose a suitable model. 
4.2.1. Irreversibility of thermal denaturation 
The thermal denaturation of this hemocyanin has been determined to be irreversible due to a lack of 
endotherm upon rescanning of the denatured protein (as shown in Figure 4-4).  Samples were heated 
from 40oC to 95oC at 1 K min-1 before cooling and reheating. 
 
Figure 4-4 (A) DSC Trace of native hemocyanin in TRIS buffer pH 7.6 at 1 K min-1; (B) Rescan of 
denatured hemocyanin showing no endotherm upon reheating 
 
In no case was an endotherm observed after heating the sample past its denaturation transition.  To 
investigate if secondary processes such as aggregation were occurring during the onset of 
denaturation, samples were then heated to the denaturation onset before cooling and rescanning 
through the transition.   
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Two distinct denaturation peaks were observed for the unfolding of this hemocyanin.  A previous study 
noted the possible existence of a second shoulder on the hemocyanin denaturation endotherm [74] 
indicating a complex unfolding without complete deconvolution.  The improved separation of these 
peaks in this study may be attributed to the higher resolution of the TA nanoDSC instrument we used.  
The separation of these peaks (Figure 4-4) indicates that the two denaturations are distinct and the 
removal of only the first peak in the onset scan (Figure 4-5) confirms that their progression is 
independent of one another. 
Deconvolution techniques may be used to model the separate peaks determine the activation energy 
of the second peak [74], however this would require inferring an unknown slope to the onset of the 
partially covered second peak.  As the Sanchez Ruiz model is highly sensitive to the slope of the 
denaturation onset [40], the deconvoluted peak was considered too unreliable to be evaluated by this 
method. 
 
Figure 4-5 (A) DSC scan ramping to 75oC to measure onset of denaturation. (B) Rescan of 
hemocyanin sample after onset scan 
 
When the hemocyanin samples were heated to the onset of denaturation, then cooled and rescanned, 
a smaller denaturation peak was observed indicating that a partial unfolding had occurred (Figure 4-5).  
The presence of an endotherm on the rescan indicates that the denaturation did not then proceed 
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through aggregation. It was therefore concluded that the denaturation is entirely irreversible and this 
is not the result of destructive high temperature processes. 
In order to determine if the transition was kinetically controlled, the dependence of Tm on scan rate 
was established, as shown in Figure 4-6.  
  
 
Figure 4-6 DSC traces for hemocyanin at scan rates of 0.2, 0.6, 1, 1.4 and 2 K min-1 indicating that Tm 
is scan rate dependent 
 
The denaturation temperature varied from 75.5-80.5 oC, increasing with increase in scan rate. This 
was expected as the kinetic theory of irreversible denaturation requires a dependence of peak position 
on scan rate. This happens due to the heating rate and denaturation rate being of a similar scale. The 
transition is therefore under kinetic control. 
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Table 4-2: Hemocyanin Tm variation with scan rate 
Scan Rate (K 
min-1) 
Tm /°C 
0.2 75.5 
0.6 77.5 
1.0 79.0 
1.4 79.5 
2.0 80.5 
 
Irreversibility of hemocyanin denaturation has been observed for other species such as the Gastropod 
Rapana Thomasiana [74] and  the Arthropod Pulinurus Vulgaris [43].  Reversible denaturation has not 
been observed for any hemocyanin to date.  The presence of visible aggregates in denatured samples 
suggests that aggregation effects occur simultaneously to the denaturation. As this reaction leads to 
irreversibly unfolded proteins, it is expected that the exposed internal residues will be drawn together 
to lower unfavourable interactions and leading to aggregation.  
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4.2.2. Concentration dependence  
As hemocyanin forms an oligomeric structure, separation of the individual subunits may occur during 
the denaturation process.  In order to determine if this is occurring, DSC traces were collected at 
varying protein concentrations (Figure 4) from 0.19 - 0.64 mg mL-1 at a constant scan rate of 1 K min-
1.   
 
Figure 4-7 DSC traces of hemocyanin at 0.19, 0.39, 0.64 mg mL-1 
The initial denaturation peak for each of these samples was measured to be 79.0 oC, indicating that 
the denaturation temperature is independent of concentration over the range of 0.19-0.64 mg/mL. 
This leads to the conclusion that the rate determining step of the transition does not involve a change 
of oligomeric state. Whilst a change in oligomeric state may occur in concentrations outside this range, 
this data shows that a change of oligomeric state is not inherent to the denaturation reaction. Changes 
in oligomeric state by definition result in a change in concentration, and if this was to occur, Le 
Chateliers Principle would require a resultant reaction, altering the kinetics of the reaction. As this was 
not observed, no change in oligomeric state could have occurred.  It should be noted, however, that 
this does not preclude changes in oligomeric state following the rate determining denaturation.  
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4.2.3. Activation Energy parameters 
The Sanchez-Ruiz method [40] allows for the calculation of the activation energy for a particular 
transition assuming that it follows the two state mechanism 
𝑁
𝑘𝐷
→ 𝑈 
where the unfolding occurs at a reaction rate (kD) and follows the Arrhenius relation: 
𝑘𝐷 = 𝐴. 𝑒𝑥𝑝(−𝐸𝑎/𝑅𝑇) 
To demonstrate whether the reaction follows the above mechanism, four different simplifications of 
the Arrhenius equation are then derived based on the four different assumptions below which must 
each be true, and will yield the same activation energy (Ea), if the reaction is irreversible and under 
kinetic control.  If each of these relations hold, then as shown by Sanchez-Ruiz [12], the mechanism 
determined is an accurate one for the denaturation process and the activation energy of the transition 
is given by the average value obtained from the four methods. 
Whilst the peak position of an irreversible denaturation may change with approach rate, the activation 
energy for a particular transition is theoretically consistent and the Arrhenius plots are linear.  If the 
transitions were reversible, this would not hold true.  
Method A 
 
Method A is based on the premise that the rate of heat evolution is proportional to the activation 
energy[40].  This rate may be calculated as follows: 
𝑘𝐷 = 𝑣𝐶𝑝/(𝑄𝑡 − 𝑄) 
Where the rate constant for the denaturation reaction kD is dependent on the scan rate (v) the total 
heat of the transition (Qt) and the heat capacity (Cp) and heat evolved up to a particular temperature. 
If the transition follows the behaviour of an irreversible transition, then the rate constant can be 
equated to the Arrhenius equation. Plotting 1/T vs. ln(kD) (Figure 4-8) helps to linearise this relation 
with the slope equal to  𝐸𝑎/𝑅 .   
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Figure 4-8 Method A to determine Ea for hemocyanin. Scan rates of 0.6, 1, 1.4 and 2 K min-1 shown 
The slope of each data set, and hence the activation energy, was determined independently yielding 
an average activation energy of 588 ± 29 kJ mol-1 across the samples. 
Method B 
The second method relates the change in melting temperature to the scan rate at which the melt 
temperature is recorded.   This scan rate dependence is proportional to the activation energy of the 
protein:  
 
𝑣
𝑇𝑚
2 =
𝐴𝑅
𝐸𝑎
𝑒
−
𝐸𝑎
𝑅𝑇𝑚 
A plot of ln (𝑣/𝑇𝑚
2) vs 1/𝑇𝑚 , with a slope of Ea/R, was derived and is shown in Figure 4-9. 
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Figure 4-9 Hemocyanin activation energy as a function of scan rate from 0.2 - 2.0 K min-1 
This method was applied to five scan rates from 0.2 – 2.0 K min-1 (Figure 4-9).  The analysis yielded an 
activation energy of 464 kJ mol-1.  This is significantly lower than that calculated via Method A; 
however method B may have higher uncertainty as it uses only peak position to determine stability. 
 
Method C  
For method C, the rate of energy evolution within the system is proportional to the activation energy 
barrier preventing energy evolution, through the following relationship: 
ln (ln (
𝑄𝑡
𝑄𝑡 − 𝑄
)) =
𝐸
𝑅
(
1
𝑇𝑚
−
1
𝑇
) 
When the left hand side of the expression is plotted against 1/T (Figure 4-10) then the slope will be 
equal to Ea/R.   
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Figure 4-10 Hemocyanin Ea as determined by method C: rate of energy evolution 
The slope of each data set was derived independently yielding an average activation energy of 𝐸𝑎 =
591 ± 120  kJ mol-1 which is in close agreement with the value obtained by Method A. 
 
Method D 
The fourth method directly calculates the activation energy based on the total energy released at the 
denaturation peak.  This is related as follows: 
𝐸𝑎 = 𝑒𝑅𝐶𝑝
𝑚𝑇𝑚
2/𝑄𝑡 
The activation energy was estimated for each of the samples as shown in Table 3. 
Table 4-3 Hemocyanin Ea variation with scan rate 
Scan rate /K min-1 Ea /kJ mol-1 
0.6 434 
1.0 512 
1.2 549 
1.4 545 
2.0 451 
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Using method D, an average activation energy of 498 ± 50 kJ mol-1 was computed which is in 
agreement with the value obtained via method A. 
Thus it was established that the denaturation of Haliotis Rubra hemocyanin could be reliably modelled 
as an irreversible denaturation through the method of Sanchez-Ruiz. Whilst methods A through D 
should theoretically provide the same result for the activation energy, this rarely seems to occur in 
literature and the agreement found here (464-591 kJ mol-1) is within what has been previously 
published (Table 3-1). 
Table 4-4: Denaturation temperatures for various hemocyanins 
Hemocyanin Species Technique Tm /oC Ea /kJ mol-1 
Haliotis Rubra (This work) DSC 76.3 528 ± 63 
Palinurus Vulgaris [43] DSC 63.1 383 ± 30 
Rapana Thomasiana [74] DSC 83.0 597 ± 20 
Helix Pomatia [90] DSC 85.7 517 ± 27 
Megathura Crenulata [73] CD 68.0 - 
Haliotis Tuberculata [73] CD 76.0 - 
Rapana Thomasiana [73] CD 79.0 - 
Helix Pomatia [76] FTIR 81.0 - 
Eurypelma Californicum[91] DSC 89.9 - 
 
 
This data is also similar to that found for hemocyanins from other species, such as Gastropod Rapana 
thomasiana ( 𝐸𝑎 = 597 ± 20 kJ mol
−1 ) [74] and Arthropod Pulinurus vulgaris ( 𝐸𝑎 = 383 ±
30 kJ mol−1 ) [43] using DSC. Analysis of the stability of various formulations of Haliotis Rubra 
hemocyanin will therefore be analysed by this procedure. 
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4.3. Aggregation behaviour 
4.3.1.  Change in particle size with temperature 
One key factor in the stability of a protein in solution is its ability to resist aggregation, as protein 
aggregates are generally biologically inactive and therefore not in their stable native state. As was 
established in Chapter Three, native hemocyanin is an extremely large protein (approximately 40nm) 
and it is possible to measure the particle size of its native conformation directly through use of photon 
correlation spectroscopy. It was also determined that aggregates can be identified via this method. In 
order to test the stability of the sample, we will now investigate the temperature at which aggregation 
begins and the rate at which it progresses.  
As the Malvern Zetasizer does not have an accurate differentially controlled heating apparatus, 
discrete measurements every 1oC have been made during increasing temperature and as such no 
differential action can be displayed in this data.  It does, however give some insight into the point of 
aggregation onset.  In Figure 4-11 the onset of aggregation is shown for a system of hemocyanin 
dialysed into deionised water. Samples of hemocyanin, dialysed into MilliQ water, with no adjuvants, 
were filtered through a 22mircon filter into the sample tubes. Following the method outlined in 
Chapter 3, Z average distributions of the particle size were then measured every 1oC. The diameter of 
the most prominent peak is shown here for each measurement.  
 
Figure 4-11 Aggregation profile as a function of temperature for hemocyanin in water 
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As shown in Figure 4-11 aggregation is seen to begin at approximately 75oC in a pure water 
environment and shows how the hemocyanin rapidly aggregates as the temperatures rises above this. 
The aggregation onset appears to coincide with the denaturation temperature of the hemocyanin as 
may be expected due to the exposure of normally hydrophobic residues to the solution. 
 
4.4. Conclusions 
 
In this chapter we have discussed the thermal stability of Haliotis Rubra hemocyanin, with a focus on 
the application of differential scanning calorimetry to the study of hemocyanin denaturation. The 
study of calorimetry equipment discovered that the TA nanoDSC can provide high resolution DSC 
traces, without the onset of aggregation during the denaturation transition. Other equipment, 
however, could not avoid this aggregation, making the choice of calorimeter important in obtaining 
viable DSC data. 
Calorimetric traces have been obtained for the first time for the hemocyanin from Haliotis Rubra, 
with a denaturation temperature of 76.3oC showing that the stability of the pure protein was 
comparable to that from other species. Like all hemocyanins which have been studied, the 
denaturation reaction was found to be entirely irreversible, necessitating the use of irreversible 
denaturation models for its study. The method of Sanchez-Ruiz was therefore applied, identifying an 
activation energy for the denaturation reaction of 528 ± 63 kJ mol-1.  
It was determined that whilst the hemocyanin has a complex quaternary structure, this oligomeric 
form does not change during the denaturation. Aggregation, however, does occur alongside 
denaturation, with all samples showing visible aggregates upon removal from the calorimeter. We 
therefore investigated the aggregation behaviour of the protein using photon correlation 
spectroscopy in a Malvern zetasizer. This method is not generally applied to the study of proteins as 
the minimum size of particle for monitoring is above that of most proteins. By placing the protein 
sample into the zetasizer and scanning up in temperature we observed the onset of aggregation for 
the protein at 76oC, simultaneously to the denaturation. This is a simple and effective method for 
measuring the aggregation state of large proteins and may be widely applicable to the study of other 
large aggregating proteins. 
By defining the stability of pure Haliotis Rubra hemocyanin, we have been able to construct a picture 
of the thermal stability of this protein. This will allow a benchmark of stability which we can then 
improve upon with formulation studies in the following chapter. 
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Chapter 5:  
Improved Hemocyanin Stability  
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CHAPTER 5. Improved hemocyanin stability through formulation 
Previous chapters have established the inherent properties of Haliotis Rubra hemocyanin and found 
that without improvements to the stability of our formulations, the hemocyanin rapidly denatures 
and aggregates when stored in water solutions. In order to create viable pharmaceuticals from the 
hemocyanin, we must create formulations which allow the protein to remain stable through testing 
and administering of the therapeutic.  
To this end, Haliotis Rubra hemocyanin will be formulated with a series of excipients which are often 
used in protein formulations. Many additives, such as buffers, salts and sugars are often added into 
protein formulations to increase stability, however the relative effect of each of these additives may 
be specific for to the protein chosen and as such their effects must be studied individually if we wish 
to create an optimal formulation. 
Whilst no other studies have been aimed directly at formulating the hemocyanin from any organism, 
studies into the thermal characteristics of other hemocyanins do provide a range of initial 
formulations which we will investigate. Further, studies into the formulation of other, usually much 
smaller and conformationally simpler proteins, give some clues as to which formulating agents are 
worth considering in combination with hemocyanin. Sugars are found to have generally stabilising 
effects, while the choice of salts, pH and buffer may have various results. 
In order to quantify the relative stability of a series of formulations we will primarily compare the 
denaturation temperature (Tm) and the activation energy (Ea) for the first unfolding peak, as was 
established in Chapter Four, where increased Tm or Ea indicate increased stability. Whilst it is tempting 
to consider the maximum apparent heat capacity for the peak as a measure of stability, this must be 
avoided as the prominence of this peak incorporates both the activation energy of the transition and 
the quantity of protein involved in the transition, complicating interpretation of the data. 
Measurements of the aggregation rate for the sample will be used to corroborate changes in stability. 
We intend to identify a number of excipients which promote stability and, combining them in their 
most beneficial concentrations, come to a final optimal hemocyanin formulation. If successful, this 
formulation may provide much longer term stability for the hemocyanin sample than we currently 
have, facilitating the testing of the pharmaceutical properties of Haliotis Rubra hemocyanin without 
the threat of sample degradation compromising results.  
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5.1. Formulation Method 
 
All hemocyanin samples were initially purified into a solution containing TRIS buffer at 100 mM NaCl 
as described in Chapter Three.  Samples were then further formulated into the desired environment 
by the following method. The desired buffer was mixed from dry ingredients into MilliQ water.  A 2 
mL sample containing 10 mM Hemocyanin in TRIS was placed into a 100 kDa filter tube and spun down 
to approximately200 mL in a centrifuge at 4000 rpm.  This tube was refilled to 2 mL and agitated to 
remove any protein from the membrane filter.  This process was repeated five times as per the 
method in Chapter 3 leaving a final sample of 2 mL of approximately 1 mM hemocyanin in the new 
buffer solution.  This exact concentration of this sample was then tested via the Qubit method 
(established in Chapter 3) and recorded for use in data analysis. The formulated samples were then 
tested via DSC and PCS to determine their stability properties using the methodology developed in 
Chapter Four.  
In order to facilitate a complementary range of excipients to be combined in formulation, commonly 
applied excipients were surveyed and found to fall into the following categories; buffering agents, 
ionic salts and solution modifiers (frequently sugars). These categories of excipients shall therefore 
each be investigated as means of altering hemocyanin stability. 
 
5.1. Effect of excipients on hemocyanin stability 
 
5.1.1. Effect of buffer identity 
Buffer identity plays a role in the stability of a protein formulation as it not only maintains the sample 
pH, but may interact with the protein directly through intermolecular forces or chaotropic effects. The 
buffering range and ionic charge will each play a role in the formulation stability, however as no 
general rule for the stabilising or destabilising effect of buffers exist, they will have to be tested 
specifically for the protein to be formulated [46]. 
Buffers were chosen to cover the representative sample of commonly used protein buffers as well as 
covering a range of possible buffer pH ranges as shown in Table 5-1.  As was determined in Chapter 3 
formulations in pure water as well as the commonly used phosphine buffered saline (PBS) buffer 
results in immediate aggregation of Haliotis Rubra hemocyanin and as such TRIS, the first identified 
buffer which could retain stability, has been used as our baseline buffer. A buffer concentration of 
50mM was used in all buffer tests to maintain ionic strength. 
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Table 5-1: List of buffers which may be suitable for the formulation of Haliotis Rubra hemocyanin 
Buffer species Buffering  
range (pH) 
Concentration 
used (mM) 
pH of buffer 
used (pH) 
Acetate 3.6 – 5.6 50 4.5 
Phosphate 5.8 - 8 50 7.4 
HEPES 6.8 – 8.2 50 7.4 
TRIS 7.3 – 9.0 50 7.4 
PBS 7.4 50 7.4 
Glycine/NaOH 8.4-10.6 50 8.5 
 
The buffers have been divided here into those which provided a more stable hemocyanin sample 
compared to water and those which destabilised hemocyanin compared to a water formulation. This 
was determined by the shape of the calorimetric traces collected, where destabilising buffers tended 
to create multiple poorly resolved denaturation peaks. This is attributed to the protein having already 
partially unfolded in the buffer environment, creating unexpected transitions. Figure 5-1 shows the 
destabilising buffers. 
 
Figure 5-1 DSC traces of Haliotis Rubra hemocyanin in buffers that reduce stability 
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Initially we attempted to formulate hemocyanin into PBS buffer as it was the reported buffer used for 
formulations of hemocyanin from Megathura Crenulata, however we discovered that this resulted in 
denaturation and aggregation of Haliotis Rubra hemocyanin as can be seen by the lack of distinct 
peaks in Figure 5-1. Buffers which could be used at a neutral pH were formulated to pH 7.4 and the 
others were formulated within their buffering range as stated below. 
Buffers which destabilise hemocyanin may do so for a variety of reasons. Acetate buffer at pH 4.5 was 
destabilising, as expected, due to having a pH close to the isoelectric point of the protein. 
Glycine/NaOH buffer at pH 8.5 however was also destabilising, despite being far away from the 
isoelectric point. PBS buffer, which was a purchased standard at pH 7.4, also destabilised the 
hemocyanin, potentially due to the other ions formulated into this standard buffer. 
Each of the buffers which destabilised hemocyanin was also observed to promote aggregation of the 
sample, with visible aggregates presenting when stored for 24 hours. This further indicates their lack 
of suitability. 
Figure 5-2, shows buffers which were stabilising. These buffers were all formulated by hand to a pH of 
7.4 and had no additional ions beyond the buffering agent and its titrant.  
 
Figure 5-2 DSC traces of Haliotis Rubra hemocyanin in buffers which promote stability 
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It can be seen for stabilising buffers that the denaturation temperature of the Haliotis Rubra 
hemocyanin changed with the buffer identity (Table 5-2), indicating that the buffering species is 
actively involved in the denaturation reaction. 
 
Table 5-2 Comparative denaturation temperatures for Haliotis Rubra hemocyanin in various buffers 
prepared to 50mM 
 Tm 
Water 73.8 
Phosphate 76.8 
Tris 78.0 
HEPES 79.0 
 
HEPES was found to be the most stabilising buffer for this hemocyanin formulation; however TRIS also 
provided a suitable buffer environment. Phosphate, whilst stabilising, was not as effective. Thus in the 
combined final formulation, HEPES will be used to provide the greatest stabilising effect, however for 
the investigation of other factors such as ionic strength, a TRIS based buffer was utilised, as it was the 
first buffer identified to provide a stable formulation.  
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5.1.2. Effect of ionic strength 
Once a suitable buffer had been chosen, with TRIS being the first suitable buffer identified, we set to 
investigate the optimal ionic strength for a stable sample. In order to have effective buffering a 
minimum buffer concentration of 50 mM of the buffer was used. Sodium Chloride was then added to 
increase the ionic strength up to 500 mM. As Haliotis Rubra is a sea based animal an ionic strength of 
500 mM, similar to sea water, was anticipated to increase stability. 
Salts are generally used to increase the ionic concentration and conductivity of protein formulations. 
It was discovered in initial denaturation studies that hemocyanin in pure water rapidly aggregated and 
denatured, such behaviour potentially arising from the lack of ions in solution which could stabilise 
the protein.. Hence, all further formulations were created with a minimum of 100mM NaCl as well as 
the buffering agent.  
 
 
Figure 5-3 Aggregation of hemocyanin in high salt concentration TRIS buffer 
As it can be seen in Figure 5-3, the Haliotis Rubra hemocyanin denatured and aggregated at low 
temperatures, indicating a heavily reduced stability. The observed rapid drop in apparent heat 
capacity is the result of protein aggregation, and is characteristically observed when the hemocyanin 
sample aggregates. Visual observation of the aggregated sample after testing confirms that 
aggregation occurred. Whilst this concentration has been found to promote stability for some 
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proteins[50], the effects can vary, in this case being highly destructive. Lower salt concentrations were 
then used to find an optimal point. 
As hemocyanin formulations lacking any salt have previously been seen to aggregate in a similar 
manner, the range of salt concentrations for this study was amended to 50-200 mM allowing us to 
maintain a sample without aggregation through the denaturation transition. 
 
Figure 5-4 Changes in hemocyanin denaturation rates with change in ionic concentration 
 
In Figure 5-4 it can be seen that whilst the peak position for the hemocyanin denaturation transition 
is unchanged by the salt concentration, the volume of the peaks, and their activation energy change 
dramatically. A maximum stability was recorded at 100 mM and this concentration was therefore 
adopted for further formulations. 
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5.1.3. Effect of salt valence 
Whilst initial tests were conducted with simple monovalent salts, it was anticipated that adding salts 
of different valences may lead to different effects on the stability of hemocyanin due to the cross 
bonding effect of diavalent ions.  Taking the previously determined optimal salt concentration, we 
then substituted divalent anions and cations to determine their effect on hemocyanin stability. 
 
Figure 5-5 Effect of changing both anion and cation valence on the stability of Haliotis Rubra 
hemocyanin 
It was observed that whilst changing the valence of anions had a very minor effect on the stability of 
hemocyanin (Figure 5-5), the presence of divalent cations in the hemocyanin formulation dramatically 
increased the prominence of the initial denaturation peak at the expense of the second denaturation 
peak. 
A number of possible explanations for this behaviour are hypothesised. As was previously discussed 
in Chapter Four, it is possible that the first and second denaturation peaks represent a number of 
different transitions and without isolating hemocyanin into individual chain subunits it is impossible 
to prove what each transition represents. However, if the two denaturation peaks represented the 
individual unfolding of separate subunits, then the data in Figure 5-5 would suggest that divalent 
cations highly stabilised one subunit at the expense of the other.   
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If, on the other hand, the first transition represents the breaking of the hemocyanin quaternary 
structure and the second represents a subsequent unfolding step, then this data would suggest that 
divalent anions help maintain the quaternary structure of the hemocyanin during the entire 
denaturation, thereby leaving less free subunits to unfold subsequently.  As the prominence of the 
initial unfolding transition is increased so dramatically, the second hypothesis appears more likely.  
However, until individual subunits of the Haliotis Rubra hemocyanin can be isolated it may be 
impossible to prove which of these mechanisms is in effect. 
  
5.1.4. Effect of sugar concentration 
Sugars are frequently added to protein formulations to increase stability. As was discussed in the 
literature review (Chapter 2), this is attributed to an increase in ordering of water around the protein 
as the sugar is excluded from its surface. We therefore anticipate that increasing sugar concentrations 
will only favour stability for the protein. Sucrose was chosen as the model sugar for this experiment, 
due to its frequent use in protein formulation.  
 
Figure 5-6 Effect of increasing sugar content on hemocyanin stability 
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It can be seen in Figure 5-6 that the denaturation temperature of the protein is not dependant on the 
sugar concentration. This may be anticipated, as the excluded sugar is not directly changing the 
structure of the hemocyanin. The shape, and therefore the activation energy of the denaturation, 
however, is seen to change.  
Table 5-3 Activation Energy parameters for Haliotis Rubra hemocyanin in solutions at various 
sucrose concentrations 
Sucrose 
Concentration 
(mg mL-1) 
Tm (oC) 
Activation 
Energy 
(kJ mol-1) 
0.1 75.03 472 
1 75.11 530 
10 74.96 545 
100 75.09 557 
Sol Lim 75.15 371 
 
Up until 100 mg mL-1 the denaturation activation energy and hence protein stability increases. It was 
found, however, that increasing that sugar concentration further, up to the solubility limit (, resulted 
in a stability decrease (Table 5-3). This may be a result of sugar precipitation directly affecting the 
hemocyanin. A sugar concentration of 100 mM will therefore be applied to further samples. 
 
5.1.5. Effect of sugar identity 
It was anticipated that all sugars stabilised hemocyanin by the same mechanism, and hence should 
yield similar gains to formulation stability, however as the regulatory approvals and costs vary 
between sugars we have chosen to investigate a number of options. Hemocyanin in Tris, was 
formulated with 100 mM of glucose, fructose, xylose and arabinose.  
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Figure 5-7 Effect of various monosaccharides on Haliotis Rubra hemocyanin 
In Figure 5-7 we see that all the monosaccharides tested provided a similar and effective increase to 
hemocyanin stability. 
The size/Mw of the sugars was also examined. Here, we have compared a monosaccharide (glucose), 
a disaccharide (sucrose) and a trisaccharide (raffinose) to compare the effect of the sugar size on its 
stabilising effect. The molar concentration, not mass of sugar was maintained as the osmotic forces 
excluding water from the protein surface are dependent on the molar concentration of sugar osmolyte 
in the solution. 
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Figure 5-8 Effect of changing polysaccharide size on Haliotis Rubra hemocyanin 
 
It can be seen that the effect of changing sugar molecular weight was more dramatic than the change 
between various monosaccharides, which may be expected as the chemical difference between the 
monosaccharides is extremely minor, whereas the mass and hence intermolecular forces between 
other polysaccharides may be different. 
 
Table 5-4 Effect of Sugar identity on the stability of Haliotis Rubra hemocyanin 
Sugar 
identity 
Sugar Size 
g mol-1 Tm (oC) 
fructose 180.16 80.9 
arabinose 150.13 80.9 
glucose 180.16 81.0 
xylose 150.13 81.0 
sucrose 342.30 81.2 
raffinose 504.42 81.5 
 
It was still found, however, that the identity of sugar was far less important than the concentration of 
sugar within the sample when affecting the hemocyanin denaturation activation energy. Sucrose has 
been chosen, instead of Raffinose, as the stabilising agent for further formulations. Whilst Raffinose 
was slightly superior in stabilising the hemocyanin, we found this difference to be minor and sucrose 
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has the advantage of being a much cheaper and more frequently used adjuvant than raffinose. This 
will allow for easier drug approval for the combined formulation, an important factor. 
 
5.1.6. Combined hemocyanin formulation 
Based on the above data for the most stabilising buffer, salt, and sugar conditions, a final combined 
formulation was created. In it 50mM HEPES at pH 7.4 with 100 mM NaCl and 100 mM sucrose was 
formulated with 1 mg mL-1 Haliotis Rubra hemocyanin. The stability of this formulation, compared 
with a base sample of hemocyanin in pure water is shown in Figure 5-9. 
 
Figure 5-9 DSC curve for Haliotis Rubra hemocyanin in the most stable formulation identified, 
containing 50mM HEPES at pH 7.4 with 100mM NaCl and 100mM sucrose with 1mg mL-1 Haliotis 
Rubra hemocyanin 
 
The final combined formulation was found to be highly stable with a denaturation temperature of 
78.9oC and a denaturation activation energy of 726 kJ mol-1, a stabilisation of 38%.  
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Table 5-5 Comparative stability of Haliotis Rubra hemocyanin in water and in an optimised 
formulation 
 Tm (oC) Ea (kJ mol-1) 
Hemocyanin in water 73.7 311 
Final Hemocyanin formulation 78.9 726 
 
This combined formulation of Haliotis Rubra hemocyanin is the most stable we have yet recorded. It 
remains yet to be seen, however, if this will translate to reduced aggregation rates or a long term 
stability of the sample, which will be crucial for the therapeutic testing of the protein. 
The aggregation rate of the final sample was then measured following the same method used in 
Chapter 4, as shown in Figure 5-10. 
 
Figure 5-10 Aggregation behaviour of Haliotis Rubra hemocyanin in water compared with an optimised 
formulation 
It can be seen that the formulated sample aggregates much less readily than pure hemocyanin in 
water. Whilst the pure sample begins aggregating around 72oC, the formulated one has not undergone 
any aggregation up to the maximum temperature of the zetasizer machine (78oC). This improvement 
in reducing aggregation rates will be crucial in the long term stability of the protein, as any aggregation 
of the sample will lead to irreversible loss of protein from the formulation.   
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5.2. Stability of hemocyanin after storage 
Whilst we have now confirmed that an improved formulation could enhance the stability of 
hemocyanin in the short term, we are yet to determine if this translates to the long term stability 
required of a pharmaceutical product. In order to assess this, the completed Haliotis Rubra 
hemocyanin samples were then stored for a period of nine months and then retested. 
 
Figure 5-11 DSC traces of Haliotis Rubra hemocyanin formulations after nine months of storage as 
either a liquid or a freeze dried solid 
Figure 5-11 shows that whilst there was some degradation of the hemocyanin over the storage period, 
a large portion of the sample retained its native state, producing a reasonable DSC trace. Freeze 
drying, whilst further reducing the stability of the sample, also retained most of the stable 
hemocyanin.  
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This was verified via particle sizing in Figure 5-12 where the particle size of fresh hemocyanin is 
compared to those measured for the samples stored for nine months. 
 
Figure 5-12 Particle sizes of Haliotis Rubra hemocyanin formulation and its stored forms 
 
It can be seen that a large degree of aggregation has occurred over the nine months of storage, with 
the hemocyanin in liquid form performing worse than the freeze dried sample. This is, however, 
expected due to the inherent instability of the hemocyanin material. However, as the sample did not 
form extremely large aggregates, as is observed in all other denatured samples, we suggest that much 
of this sample is still in its native form. Further, as DLS can be over-influenced by larger particles, it is 
possible that far more of the hemocyanin is in the didecameric form of 43nm that appears from this 
data. Thus there is a large portion of the protein which is not aggregated. Considering that this sample 
also showed strong DSC peaks and is hence still folded, we anticipate that the sample is still active. 
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5.3. Conclusions 
 
Haliotis Rubra hemocyanin is a promising antiviral candidate, however in its pure form a lack of 
stability means that its efficacy trials would be compromised by a lack of active protein during 
testing. We have, therefore, formulated the protein in order to stabilise its native state and create a 
sample which does not denature or aggregate under normal storage conditions. 
The effect of buffers, salts and sugars have been investigated as candidate stabilising adjuvants. 
Whilst it was found that all sugars promoted stable formulations, likely due to the excluded volume 
effect, with a maximum suitable concentration only limited by the solubility of the sugar. Buffers 
were found to have specific interactions with the protein, resulting in either a strongly destabilising 
effect or a promotion of stability and increase of denaturation temperature. Both TRIS and HEPES 
were strongly stabilising. Salts were found to stabilise the protein at some concentrations, as long as 
divalent cations were not included, with an optimum concentration of 100mM observed.  
In order to combine the stabilising adjuvants into a single formulation we identified the optimum 
mixture to be a 50mM HEPES at pH 7.4 with 100 mM NaCl and 100 mM sucrose was formulated with 
1 mg mL-1 Haliotis Rubra hemocyanin. This resulted in a stabilised formulation with a denaturation 
temperature of 78.9oC and a denaturation activation energy of 726 kJ mol-1, a stabilisation of 38%.  
This sample was then stored for nine months, with the sample retaining its thermal stability and 
oligomeric state. The sample was found to have aggregated to some degree, however degraded to a 
much lesser extent than was observed for unformulated samples. As we have formulated the protein 
into a solvent with FDA approved adjuvants and proven long term stability, the hemocyanin sample is 
now suitable for therapeutic testing. Creating a stable hemocyanin formulation will allow for viable 
drug testing and will show the true efficacy of native Haliotis Rubra hemocyanin. 
 
  
74 
Gavin Marshall PhD Thesis 
 
 
 
 
 
 
 
 
 
Chapter 6:  
Conclusions and  
Further Directions  
75 
Gavin Marshall PhD Thesis 
CHAPTER 6. Conclusions and Further Directions 
 
6.1. Conclusions 
 
The aim of this work was to characterise the hemocyanin from Haliotis Rubra and develop a suitable 
formulation for pharmaceutical applications. Our research group has been studying this protein as it 
has been demonstrated to have activity against Herpes Simplex Viruses, which our research group has 
been studying. [1, 2, 92] This activity is very promising as the current treatment options for Herpes 
viruses are limited [13]. This activity is also not entirely surprising as recent studies have identified 
antiviral behaviours in hemocyanins from different species. The activities of these various 
hemocyanins appear to be species dependant however[9, 80] and as such we have found that this 
warrants individual studies on the hemocyanins from Haliotis Rubra individually.  
  
Both the characterisation and formulation of the hemocyanin from Haliotis Rubra are tasks of 
considerable difficulty due to the extremely large size of the protein (over 7 MDa). The vast majority 
of existing techniques for both the characterisation and formulation of proteins are suited to much 
smaller molecules, meaning a key aspect of this work was developing suitable measurement and 
formulation methods for large proteins.  
 
The first section of this work involved the both the purification and characterisation of the 
hemocyanin, as this was felt to be a necessary first step in the development of a stable formulation. A 
range of techniques for the purification of the protein were examined in Chapter 3; again the large 
size of the protein presented several unique challenges. It was found that by applying an innovative 
filtration process it was possible to produce a relatively high-purity hemocyanin solution.  
 
 As previously noted the characterisation of such large proteins is a topic which is not widely addressed 
in the open literature and hence it was necessary to develop suitable experimental techniques to 
address this important challenge. A range of techniques including Differential Scanning Calorimetry, 
Photon Correlation Spectroscopy, Mass Spectrometry and Gel Electrophoresis were used to 
determine the size, charge and sequence of the Haliotis Rubra hemocyanin. Through mass 
spectrometry we discovered that Haliotis Rubra hemocyanin was closely related to that of Haliotis 
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Tuberculata, and surprisingly that it did not share much homology to that of the widely studied 
Megathura Crenulata explaining why we did not observe much similarity between the stability 
properties of the hemocyanins from these organisms. Using dynamic light scattering we also 
discovered that the hemocyanin has a solvated diameter of 43 nm, similar to the measured size of 
Megathura Crenulata didecamers, suggesting that a similar structure was also present in the Haliotis 
Rubra hemocyanin. Further, the isoelectric point of the hemocyanin was found to be 5.97, determining 
that we must avoid this pH in Haliotis Rubra hemocyanin formulations. 
 
The second stage of the thesis examined the stability of the hemocyanin. Once more, the size of the 
protein presented a challenge in terms of identifying suitable measurement techniques; however, it 
was found that Digital Scanning Calorimetry (DSC) was able to provide suitable information about the 
protein stability. Such knowledge is undoubtedly crucial; as it allows the effect of any additives to be 
quantified, which is a key focus of the work.  
 
As was investigated in Chapter Two, much has already been said on the stability of proteins going back 
as far as the 1950s [25, 34]. Despite the similarity in structure of all proteins, as folded polypeptides, 
we see a range of stability parameters which varies far more than those for synthetic polymers. The 
expected irreversibility of hemocyanin denaturation reactions also creates a challenge in analysing the 
thermodynamic properties inherent in stability. We, therefore identified the method laid out by 
Sanchez-Ruiz [40], which analyses the activation energy barrier to unfolding as a proxy for 
thermodynamic stability as the most viable framework for analysing the stability of this irreversible 
transition.  
 
Previous studies into the stability of hemocyanins have also been used as a basis for our investigation. 
We found that whist all hemocyanins observed have been seen to unfold irreversibly, they show a 
remarkably large range of both denaturation temperatures (63.1-89.9oC [43, 91]) and activation 
energy profiles (383.3 – 597 kJ mol-1 K--1  [43, 74]), giving a wide range of parameters within which we 
might expect to find Haliotis Rubra hemocyanin stability. This highlights the difference between 
hemocyanins which may explain their disparate therapeutic effects as well as their varying stability.  
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Before any changes to formulation could be considered, the stability of pure hemocyanin in water was 
investigated. This allowed us to develop a baseline reading for stability, and to test and validate our 
methods. The denaturation of hemocyanin was confirmed as an entirely irreversible reaction, and was 
therefore characterised by its kinetic parameters. The method of Sanchez-Ruiz was applied in order 
to quantify the activation energy with an activation energy of 464-591 kJ mol-1 which was consistent 
with that measured for other hemocyanins. This data was the core of our publication “Thermal 
denaturation and protein stability analysis of Haliotis rubra hemocyanin” [2]. 
 
It was also expected that aggregation accompanied the denaturation of hemocyanin and as such we 
set to monitor this using dynamic light scattering. DLS allowed us to observe the aggregation of 
hemocyanin from monodisperse 32nm particles into large aggregates, and it was confirmed that this 
occurred simultaneously to the denaturation temperature. 
 
As the stability of hemocyanin in water was far too low for drug trials we then set about improving 
that stability through formulation of the protein. Whilst buffers such as PBS have been successfully 
applied to formulations of other hemocyanins, we found that PBS led to rapid aggregation of Haliotis 
Rubra hemocyanin. Whilst these buffers may have been used in drug formulations, their use would 
have resulted in no hemocyanin activity, due to unstable proteins. Instead we identified that both TRIS 
and HEPES buffers could promote stability, both increasing the denaturation temperature of the 
protein and decreasing aggregation rates. In order to create a formulation plan, we investigated which 
adjuvants have previously been used in protein formulations and the mechanisms by which they work. 
Buffer and salt identities were considered in order to investigate the effect of specific ion interactions 
and the varying charge ratios on the solvation properties of Haliotis Rubra hemocyanin. Sugars were 
also anticipated to be a worthy addition to high stability formulation, as their addition is known to 
increase protein stability by changing the free energy of the hemocyanin water system. This allowed 
us to design a series of formulations to narrow down which interactions lead to a stabilised 
hemocyanin formulation. 
 
In order to create an optimal formulation, however, other adjuvants such as salt and sugar additions 
were then considered. It was found that, as expected, sugar additions increased the hemocyanin 
stability as well as promoting delayed aggregation. This was published in “Formulation of abalone 
hemocyanin with high antiviral activity and stability” [1]. As the sugar identity did not greatly influence 
78 
Gavin Marshall PhD Thesis 
the stability gain, we attribute this stabilisation to the preferential hydration effect, whereby the sugar 
addition changes the free energy of water in the formulation, leading to a higher overall energy barrier 
for the unfolding reaction. Salt concentration was also found to play a key role in the stability of 
hemocyanin, with an optimal salt concentration of 100 mM identified. Divalent cations were also 
found to dramatically alter the denaturation reaction character, reducing the prominence of the 
second peak. As this likely relates to reducing the stability of one hemocyanin region, divalent cations 
were avoided in further formulations. 
 
This lead us to a final formulation, combining the stabilising elements investigated which consisted of 
1 mg/mL Haliotis Rubra hemocyanin in 50 mM HEPES, 100 mM NaCl and 100 mM sucrose. This 
formulation displayed greatly increased thermal stability over hemocyanin in water alone, with an 
increase in denaturation temperature of 5.2oC, to 78.9oC and an increase in activation energy of 415kJ 
mol-1 K-1 to 726kJ mol-1 K-1. This stability increase was reflected in aggregation behaviour, where the 
sample was found not to heavily aggregate when placed in temperatures up to 80oC and over a period 
of up to nine months in refrigeration. These stability increases highly improve our chances of retaining 
stable active hemocyanin throughout drug trials. With a stable Haliotis Rubra hemocyanin sample we 
will be able to determine activity of hemocyanin against Herpes Simplex Viruses, showing the true 
efficacy of the native protein, and avoiding the risk of reduced activity due to sample degradation. 
 
6-1 Composition and properties of the final improved Haliotis Rubra hemocyanin formulation. 
Property Value Stability Improvement 
Buffer 50mM HEPES  
Ionic Salts 100mM NaCl  
Non Ionic additions 100mM Sucrose  
Denaturation Temperature 78.9oC 5.2oC 
Activation Energy 726 kJ mol-1 K-1 415 kJ mol-1 K-1 
Aggregation onset Temperature >80oC 70oC 
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6.2. Future directions 
 
This study has developed a thermo-stable formulation of Haliotis Rubra hemocyanin, suitable for 
therapeutic testing. There are many other questions, however, which may be asked about Haliotis 
Rubra hemocyanin and its products. We suggest here four broad paths further research may follow, 
namely; 
 Further investigation of hemocyanin stability properties, such as resistance to chemical 
denaturation and techniques complementary to DSC. 
 Investigation of Haliotis Rubra hemocyanin subunits. 
 Modification of hemocyanin proteins via conjugation, deglycosylation or partial digestion. 
 Genome sequencing and recombinant expression of hemocyanin or its components. 
 
Many of these avenues were attempted during the course of this research, however due to the size 
and denaturing behaviour of the protein they were unsuccessful. The techniques which were 
attempted will be briefly described below, along with potential solutions if they are known. Due to 
the success in developing a suitable formulation for the protein it is now possible to perform trials to 
determine its efficacy both in vitro and in vivo. Workers from our research group are currently 
pursuing this issue. 
 
In order to complement the thermal denaturation data we have collected in this study, chemical 
denaturation studies would be of interest. . This would involve an isothermal titration calorimetry 
method, to determine the effect of a denaturant, such as urea, would have on the protein. Whilst 
chemical denaturation was avoided in this study, due to being less directly applicable to the expected 
conditions for our hemocyanin drug tests, a chemical denaturation curve may allow us to quantify the 
solvation effects on protein stability, giving a more complete picture of the hemocyanin stability. 
Other studies into hemocyanin stability have applied techniques other that DSC, including circular 
dichroism, FTIR spectroscopy, and fluorescence spectroscopy to study thermal denaturation. Whilst 
these techniques are expected to yield similar data to that from DSC (allowing for an activation energy 
analysis), they would provide a validation of the DSC technique we applied. Both CD and FTIR methods 
were considered in this study, and preliminary trials were conducted. These tests, however, did not 
yield reasonable data. The use of a temperature controlled FTIR flow cell may allow us to collect 
accurate data on the denaturation reaction, however there are currently no suitable cells available for 
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use within Sydney University, or the surrounding universities. Similarly, the CD technology available 
did not have the precise temperature control required to measure accurate denaturation 
temperatures. This equipment is highly specialised and unfortunately, due to a lack of interest in this 
field locally, was not available. Application of these techniques could corroborate the DSC data used 
in this study. 
 
As has been described earlier, Haliotis Rubra hemocyanin forms a didecameric quaternary structure 
which can be separated into monomeric components at high pH. Investigation of these pure subunits 
may answer many of the open questions left in this research, including assignment of the two separate 
denaturation peaks as well as providing a sample to test the relative antiviral activity of subunits 
compared with the complete structure. Whilst we were successful in breaking the hemocyanin into 
subunits, as evidenced in electrophoresis and DLS experiments, separating the subunits proved much 
more challenging. Systems including high molecular weight filtration, chromatography and self-cast 
Agarose gel electrophoresis were attempted, however as the hemocyanin subunits were much more 
prone to aggregation than the didecameric structure we could not isolate them long enough for a 
stability study. Further formulations, modifications or purification techniques may allow the isolation 
of subunits, as has been done for hemocyanins from other sources. 
 
Protein modification may be one avenue to further study Haliotis Rubra hemocyanin. As the 
hemocyanin is heavily glycosylated, it is theorised that the surface sugars on the protein may have 
some impact on the therapeutic effects of the protein. We therefore attempted enzymatic 
deglycosylation to test this theory. Despite multiple attempts, the deglycosylation reaction would not 
proceed. This may be due to the tight barrel structure of the protein obscuring access for enzymes to 
the sugar moieties. Similarly, PEGylation was considered as a method for stabilising the hemocyanin, 
and more importantly the hemocyanin subunits. PEGylation of the subunits was unable to inhibit 
aggregation, and hence no viable samples could be obtained to test if the PEGylation proceeded. 
When repeated for the whole hemocyanin, no PEGylation was detected. This, however, may instead 
be due to the extreme size of the relative to the PEG reagents, which may hide the change in molecular 
mass. Successful deglycosylation or PEGylation may allow us to understand the effect the hemocyanin 
surface has on its therapeutic activity. 
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Finally, obtaining the primary sequence for Haliotis Rubra hemocyanin would allow for a more 
systematic approach to study of the protein. This would most likely involve sequencing the genome 
for the organism, as the peptide length is too long for peptide sequencing. Whilst the unique value of 
this study comes from the necessary sourcing of our protein from a blood sample, utilising a 
recombinant protein source would allow tagging and would bring our methods more in line with 
modern proteomics studies. As it may be difficult to reproduce the complex folding or post 
translational modifications of hemocyanin within a recombinant source, this may be best used to 
study the therapeutic effects of pure unmodified hemocyanin subunits. 
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